false 0000031235--12-31 Q3 3 1 1 1 1 http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 0000031235 us-gaap:ProductMember 2024-07-01 2024-09-30 0000031235 us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2024-12-31 0000031235 kodk:OngoingServiceArrangementsMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:EMEAMember 2024-01-01 2024-09-30 0000031235 kodk:BankGuaranteesAndLettersOfCreditMember 2025-09-30 0000031235 kodk:DemographicExperienceMember 2025-09-30 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 kodk:PrintMember country:US 2025-07-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:NorthAmericaMember 2025-01-01 2025-09-30 0000031235 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0000031235 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2023-01-01 2023-07-31 0000031235 kodk:PrintMember country:US 2024-01-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2024-01-01 2024-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000031235 srt:MaximumMember us-gaap:SeriesBPreferredStockMember 2025-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000031235 us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-30 0000031235 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0000031235 us-gaap:OtherCurrentLiabilitiesMember 2024-12-31 0000031235 country:US 2024-07-01 2024-09-30 0000031235 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember 2024-01-01 2024-09-30 0000031235 kodk:PrintMember srt:NorthAmericaMember 2024-07-01 2024-09-30 0000031235 kodk:LCFacilityAgreementMember 2023-12-31 0000031235 us-gaap:RetainedEarningsMember 2023-12-31 0000031235 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0000031235 us-gaap:SeriesCPreferredStockMember kodk:AfterFebruaryTwentySixTwoThousandTwentyFourMember 2023-02-26 2023-02-26 0000031235 2024-12-31 0000031235 us-gaap:SubsequentEventMember 2025-11-30 2025-11-30 0000031235 kodk:OtherMember 2025-07-01 2025-09-30 0000031235 kodk:AtTheMarketEquityOfferingProgramMember kodk:BofAMember srt:MaximumMember 2025-05-21 2025-05-21 0000031235 us-gaap:OtherCurrentAssetsMember 2024-12-31 0000031235 kodk:BrandMember 2024-07-01 2024-09-30 0000031235 us-gaap:SeriesBPreferredStockMember 2025-09-30 0000031235 country:CA 2024-01-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:FilmAndChemicalsMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 kodk:BrandMember srt:NorthAmericaMember 2025-07-01 2025-09-30 0000031235 kodk:AllOtherMember kodk:OtherMember 2025-01-01 2025-09-30 0000031235 2029-01-01 2025-09-30 0000031235 kodk:PrintMember us-gaap:EMEAMember 2025-01-01 2025-09-30 0000031235 us-gaap:ServiceMember 2025-01-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:CA 2025-07-01 2025-09-30 0000031235 kodk:AtTheMarketEquityOfferingProgramMember 2025-05-21 2025-05-21 0000031235 kodk:CashCollateralizedForWorkersCompensationObligationsMember 2024-12-31 0000031235 srt:AsiaPacificMember 2024-12-31 0000031235 us-gaap:RetainedEarningsMember 2024-06-30 0000031235 kodk:BrandMember country:US 2025-01-01 2025-09-30 0000031235 kodk:EquipmentAndSoftwareMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember 2024-01-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:US 2025-01-01 2025-09-30 0000031235 kodk:WarrantyArrangementPeriodMember 2025-01-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:EMEAMember 2025-01-01 2025-09-30 0000031235 us-gaap:ProductMember 2025-01-01 2025-09-30 0000031235 country:CA 2025-01-01 2025-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2024-07-01 2024-09-30 0000031235 kodk:AnnuitiesMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 us-gaap:SeriesCPreferredStockMember srt:MaximumMember 2025-01-01 2025-09-30 0000031235 kodk:AllOtherMember country:US 2024-01-01 2024-09-30 0000031235 us-gaap:FairValueInputsLevel2Member 2024-12-31 0000031235 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000031235 2025-01-01 2025-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2024-09-30 0000031235 srt:LatinAmericaMember kodk:PrintMember 2024-07-01 2024-09-30 0000031235 us-gaap:SeriesBPreferredStockMember 2021-02-26 2021-02-26 0000031235 us-gaap:RetainedEarningsMember 2024-09-30 0000031235 us-gaap:PensionPlansDefinedBenefitMember country:US 2025-01-01 2025-09-30 0000031235 us-gaap:OtherCurrentAssetsMember 2025-09-30 0000031235 kodk:KRIPsProjectedBenefitObligationPBOMember 2025-06-30 2025-06-30 0000031235 kodk:LCFacilityAgreementMember 2023-01-01 2023-12-31 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AllOtherMember 2024-01-01 2024-09-30 0000031235 kodk:FilmAndChemicalsMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 kodk:PrintMember 2025-01-01 2025-09-30 0000031235 kodk:AnnuitiesMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 us-gaap:CoreMember kodk:OngoingServiceArrangementsMember 2024-07-01 2024-09-30 0000031235 srt:AsiaPacificMember 2025-09-30 0000031235 country:US 2024-07-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:LatinAmericaMember 2025-07-01 2025-09-30 0000031235 2024-06-30 0000031235 2025-09-30 0000031235 kodk:BrandMember us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember 2024-01-01 2024-09-30 0000031235 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2025-01-01 2025-09-30 0000031235 kodk:TrancheTwoMember kodk:MayTwoThousandTwentySixTermLoanCreditAgreementAmendmentMember 2025-05-07 2025-05-07 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:AsiaPacificMember 2024-01-01 2024-09-30 0000031235 kodk:AmendedABLCreditAgreementMember 2023-03-14 0000031235 us-gaap:RestrictedStockUnitsRSUMember 2025-07-01 2025-09-30 0000031235 us-gaap:ForwardContractsMember 2024-12-31 0000031235 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2024-07-01 2024-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000031235 kodk:PrintMember country:CA 2025-01-01 2025-09-30 0000031235 us-gaap:PreferredStockMember 2024-06-30 0000031235 kodk:AllOtherMember 2025-01-01 2025-09-30 0000031235 srt:LatinAmericaMember kodk:PrintMember 2025-07-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:CA 2024-07-01 2024-09-30 0000031235 kodk:EquipmentAndSoftwareMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 country:BR 2024-12-31 0000031235 us-gaap:OtherNoncurrentLiabilitiesMember 2025-09-30 0000031235 kodk:PrintMember country:CA 2024-01-01 2024-09-30 0000031235 srt:NorthAmericaMember 2024-01-01 2024-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000031235 kodk:PrintMember country:CA 2024-07-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:OngoingServiceArrangementsMember 2025-07-01 2025-09-30 0000031235 kodk:CashCollateralizedForWorkersCompensationObligationsMember 2025-09-30 0000031235 kodk:PrintMember srt:NorthAmericaMember 2025-07-01 2025-09-30 0000031235 2025-01-01 2025-09-30 0000031235 us-gaap:PreferredStockMember 2025-06-30 0000031235 srt:LatinAmericaMember kodk:PrintMember 2025-01-01 2025-09-30 0000031235 us-gaap:ForwardContractsMember 2025-09-30 0000031235 kodk:AllOtherMember 2024-07-01 2024-09-30 0000031235 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-09-30 0000031235 srt:LatinAmericaMember 2024-07-01 2024-09-30 0000031235 kodk:ExtendedWarrantyArrangementsMember 2024-12-31 0000031235 kodk:SeriesCPreferredStockExchangeAgreementMember 2025-08-08 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:NorthAmericaMember 2025-07-01 2025-09-30 0000031235 2025-10-01 2025-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000031235 us-gaap:CoreMember kodk:OngoingServiceArrangementsMember 2025-07-01 2025-09-30 0000031235 kodk:AllOtherMember kodk:OtherMember 2024-01-01 2024-09-30 0000031235 kodk:GrossProfitMember 2025-07-01 2025-09-30 0000031235 kodk:CanadaAndLatinAmericaMember 2024-12-31 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000031235 us-gaap:TreasuryStockCommonMember 2024-06-30 0000031235 us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2023-01-01 2023-07-31 0000031235 us-gaap:NonUsMember 2025-09-30 0000031235 us-gaap:FairValueInputsLevel2Member 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:US 2024-01-01 2024-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2024-03-31 0000031235 kodk:PrintMember srt:LatinAmericaMember 2024-01-01 2024-09-30 0000031235 us-gaap:CommonStockMember kodk:SeriesCPreferredStockExchangeAgreementMember 2025-08-08 0000031235 kodk:BrandMember country:US 2025-07-01 2025-09-30 0000031235 us-gaap:SeriesCPreferredStockMember 2021-02-26 0000031235 us-gaap:SegmentContinuingOperationsMember 2024-07-01 2024-09-30 0000031235 srt:MinimumMember 2025-01-01 2025-09-30 0000031235 srt:MaximumMember 2025-09-30 0000031235 us-gaap:SeriesCPreferredStockMember kodk:DividendAndOtherRightsMember 2021-02-26 2021-02-26 0000031235 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0000031235 us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 kodk:LCFacilityAgreementMember 2024-12-31 0000031235 kodk:AnnuitiesMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 us-gaap:RetainedEarningsMember 2024-12-31 0000031235 kodk:PrintMember us-gaap:EMEAMember 2024-07-01 2024-09-30 0000031235 country:US 2024-12-31 0000031235 country:BR kodk:FederalAndStateValueAddedTaxesLitigationsAndCivilLitigationAndDisputesWithFormerEmployeesMember 2025-01-01 2025-09-30 0000031235 us-gaap:ServiceMember 2024-07-01 2024-09-30 0000031235 kodk:BrandMember kodk:OtherMember 2024-01-01 2024-09-30 0000031235 2025-04-01 2025-06-30 0000031235 kodk:PrintMember country:CA 2025-07-01 2025-09-30 0000031235 kodk:GrowthProductsMember 2024-07-01 2024-09-30 0000031235 us-gaap:ServiceMember 2025-07-01 2025-09-30 0000031235 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2024-01-01 2024-09-30 0000031235 kodk:LCFacilityAgreementMember 2025-01-01 2025-09-30 0000031235 us-gaap:RedeemablePreferredStockMember 2025-09-30 0000031235 us-gaap:SeriesBPreferredStockMember 2025-04-01 2025-06-30 0000031235 kodk:AnnuitiesMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 kodk:RefinancingTermLoansMember kodk:GeneralCorporatePurposesAndWorkingCapitalNeedsMember 2025-01-01 2025-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000031235 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0000031235 kodk:MayTwoThousandTwentySixTermLoanCreditAgreementAmendmentMember 2025-05-07 2025-05-07 0000031235 us-gaap:SeriesCPreferredStockMember 2024-07-01 2024-09-30 0000031235 us-gaap:EMEAMember 2024-07-01 2024-09-30 0000031235 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-01-01 2024-09-30 0000031235 srt:AsiaPacificMember 2025-07-01 2025-09-30 0000031235 2025-06-30 2025-06-30 0000031235 kodk:RefinancingTermLoansMember 2025-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AllOtherMember 2024-07-01 2024-09-30 0000031235 2027-01-01 2025-09-30 0000031235 2024-09-30 0000031235 kodk:GrossProfitMember 2024-07-01 2024-09-30 0000031235 us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 kodk:BrandMember kodk:OtherMember 2025-07-01 2025-09-30 0000031235 kodk:EquipmentAndSoftwareMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 us-gaap:SeriesCPreferredStockMember srt:MinimumMember 2025-01-01 2025-09-30 0000031235 kodk:EastmanBusinessParkRochesterNYMember srt:MinimumMember 2025-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2024-12-31 0000031235 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000031235 kodk:PrintMember country:US 2024-07-01 2024-09-30 0000031235 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2025-07-01 2025-09-30 0000031235 us-gaap:OperatingSegmentsMember 2024-01-01 2024-09-30 0000031235 country:CA 2025-07-01 2025-09-30 0000031235 kodk:NovemberTwoThousandAndTwentyFiveTermLoanCreditAgreementAmendmentMember us-gaap:SubsequentEventMember 2025-11-04 2025-11-04 0000031235 kodk:ExtendedWarrantyArrangementsMember 2025-01-01 2025-09-30 0000031235 kodk:KodakRetirementIncomePlanMember us-gaap:SubsequentEventMember kodk:ActiveParticipantsMember 2025-10-31 0000031235 srt:NorthAmericaMember 2025-07-01 2025-09-30 0000031235 country:US 2025-07-01 2025-09-30 0000031235 country:US 2025-01-01 2025-09-30 0000031235 us-gaap:SeriesCPreferredStockMember srt:MinimumMember us-gaap:OtherNoncurrentLiabilitiesMember 2024-12-31 0000031235 us-gaap:SeriesCPreferredStockMember 2024-12-31 0000031235 us-gaap:EmployeeStockOptionMember 2025-07-01 2025-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2025-03-31 0000031235 kodk:EquipmentAndSoftwareMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 kodk:PrintMember 2024-07-01 2024-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember kodk:PrintMember 2025-01-01 2025-09-30 0000031235 us-gaap:ForeignPlanMember 2024-01-01 2024-09-30 0000031235 kodk:TrancheOneMember kodk:MayTwoThousandTwentySixTermLoanCreditAgreementAmendmentMember 2025-05-07 2025-05-07 0000031235 kodk:AllOtherMember country:US 2025-01-01 2025-09-30 0000031235 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-09-30 0000031235 srt:AsiaPacificMember 2025-01-01 2025-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000031235 us-gaap:RetainedEarningsMember 2024-03-31 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:FilmAndChemicalsMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 country:US 2024-01-01 2024-09-30 0000031235 kodk:KodakRetirementIncomePlanMember 2025-01-01 2025-09-30 0000031235 kodk:OtherMember 2024-01-01 2024-09-30 0000031235 us-gaap:SeriesBPreferredStockMember 2024-12-31 0000031235 kodk:AtTheMarketEquityOfferingProgramMember 2025-05-21 0000031235 2025-03-31 0000031235 us-gaap:OperatingSegmentsMember 2025-01-01 2025-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember kodk:PrintMember 2025-07-01 2025-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:CA 2024-01-01 2024-09-30 0000031235 kodk:KodakRetirementIncomePlanMember kodk:DeferredVestedParticipantsMember us-gaap:SubsequentEventMember 2025-10-01 0000031235 2028-01-01 2025-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000031235 srt:NorthAmericaMember 2024-07-01 2024-09-30 0000031235 us-gaap:SeriesCPreferredStockMember kodk:SeriesCPreferredStockExchangeAgreementMember 2025-08-08 0000031235 kodk:PurchaseAgreementMember us-gaap:SeriesBPreferredStockMember 2021-02-26 0000031235 kodk:GrowthProductsMember 2025-01-01 2025-09-30 0000031235 us-gaap:SeriesBPreferredStockMember 2025-07-01 2025-09-30 0000031235 2024-07-01 2024-09-30 0000031235 kodk:BrandMember country:US 2024-07-01 2024-09-30 0000031235 kodk:AmendedAndRestatedTermLoanAgreementMember 2024-01-01 2024-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000031235 2025-10-31 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:AsiaPacificMember 2025-07-01 2025-09-30 0000031235 2024-01-01 2024-12-31 0000031235 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:OperatingSegmentsMember 2024-01-01 2024-09-30 0000031235 kodk:EquipmentAndSoftwareMember kodk:PrintMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AllOtherMember 2025-01-01 2025-09-30 0000031235 kodk:AllOtherMember srt:NorthAmericaMember 2025-07-01 2025-09-30 0000031235 kodk:BrandMember kodk:OtherMember 2025-01-01 2025-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:OperatingSegmentsMember 2025-01-01 2025-09-30 0000031235 2026-01-01 2025-09-30 0000031235 kodk:PrintMember 2025-07-01 2025-09-30 0000031235 us-gaap:RedeemablePreferredStockMember 2024-12-31 0000031235 us-gaap:CoreMember kodk:OngoingServiceArrangementsMember 2025-01-01 2025-09-30 0000031235 us-gaap:PensionPlansDefinedBenefitMember country:US 2025-07-01 2025-09-30 0000031235 kodk:PrintMember 2024-01-01 2024-09-30 0000031235 kodk:PrintMember srt:AsiaPacificMember 2025-01-01 2025-09-30 0000031235 us-gaap:PreferredStockMember 2025-09-30 0000031235 kodk:PrintMember srt:AsiaPacificMember 2025-07-01 2025-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000031235 kodk:NovemberTwoThousandAndTwentyFiveTermLoanCreditAgreementAmendmentMember us-gaap:SubsequentEventMember 2026-05-16 2026-05-16 0000031235 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000031235 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000031235 kodk:PrintMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2025-07-01 2025-09-30 0000031235 kodk:PrintMember us-gaap:EMEAMember 2025-07-01 2025-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000031235 us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2024-01-01 2024-09-30 0000031235 kodk:LCFacilityAgreementMember 2023-06-30 0000031235 kodk:LCFacilityAgreementMember 2021-02-26 0000031235 kodk:OtherMember 2024-07-01 2024-09-30 0000031235 kodk:SeriesCPreferredStockExchangeAgreementMember 2025-08-08 2025-08-08 0000031235 kodk:LCFacilityAgreementMember 2025-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000031235 us-gaap:SubsequentEventMember 2025-11-04 2025-11-04 0000031235 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000031235 kodk:EquipmentAndSoftwareMember kodk:PrintMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 kodk:AnnuitiesMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 us-gaap:SuretyBondMember 2025-09-30 0000031235 kodk:PrintMember srt:NorthAmericaMember 2025-01-01 2025-09-30 0000031235 kodk:KRIPsProjectedBenefitObligationPBOMember 2025-09-30 2025-09-30 0000031235 country:BR 2025-09-30 0000031235 kodk:MortalityAndOtherDemographicExperienceMember 2025-06-30 2025-06-30 0000031235 kodk:LetterOfCreditFacilityAgreementMember 2021-02-26 2021-02-26 0000031235 us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2024-07-01 2024-09-30 0000031235 kodk:AnnuitiesMember kodk:PrintMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000031235 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000031235 kodk:BrandMember srt:NorthAmericaMember 2024-01-01 2024-09-30 0000031235 us-gaap:PreferredStockMember 2024-03-31 0000031235 kodk:AllOtherMember srt:NorthAmericaMember 2024-01-01 2024-09-30 0000031235 kodk:FilmAndChemicalsMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 us-gaap:OtherCurrentLiabilitiesMember 2025-09-30 0000031235 kodk:LCFacilityAgreementMember 2023-03-14 0000031235 kodk:CanadaAndLatinAmericaMember 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 kodk:EquipmentAndSoftwareMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:EMEAMember 2024-01-01 2024-09-30 0000031235 kodk:AllOtherMember country:US 2025-07-01 2025-09-30 0000031235 srt:MaximumMember us-gaap:ForwardContractsMember 2025-09-30 0000031235 kodk:AllOtherMember kodk:OtherMember 2024-07-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 2024-04-01 2024-06-30 0000031235 us-gaap:SeriesCPreferredStockMember kodk:PurchaseAgreementMember 2021-02-26 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:GrowthProductsMember 2025-01-01 2025-09-30 0000031235 2024-01-01 2024-03-31 0000031235 kodk:AnnuitiesMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:AsiaPacificMember 2024-07-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:AnnuitiesMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:FilmAndChemicalsMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 kodk:GrowthProductsMember 2024-01-01 2024-09-30 0000031235 us-gaap:OperatingSegmentsMember 2024-07-01 2024-09-30 0000031235 srt:MinimumMember 2025-09-30 0000031235 us-gaap:ServiceMember 2024-01-01 2024-09-30 0000031235 kodk:BrandMember srt:NorthAmericaMember 2024-07-01 2024-09-30 0000031235 kodk:RefinancingTermLoansMember kodk:UsedToRefinanceObligationsMember 2025-01-01 2025-09-30 0000031235 kodk:EquipmentAndSoftwareMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:OngoingServiceArrangementsMember 2025-01-01 2025-09-30 0000031235 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0000031235 us-gaap:EMEAMember 2025-07-01 2025-09-30 0000031235 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0000031235 kodk:LCFacilityAgreementMember 2025-09-30 0000031235 kodk:RefinancingTermLoansMember srt:MinimumMember 2025-09-30 0000031235 us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2025-09-30 0000031235 us-gaap:SeriesCPreferredStockMember kodk:AfterFebruaryTwentySixTwoThousandTwentyFourMember 2024-02-26 2024-02-26 0000031235 kodk:AmendedABLCreditAgreementMember 2023-07-31 0000031235 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember kodk:PrintMember 2024-01-01 2024-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:OperatingSegmentsMember 2024-07-01 2024-09-30 0000031235 kodk:AllOtherMember srt:NorthAmericaMember 2025-01-01 2025-09-30 0000031235 us-gaap:OtherNoncurrentLiabilitiesMember 2024-12-31 0000031235 kodk:AdvancedMaterialsAndChemicalsMember 2025-07-01 2025-09-30 0000031235 kodk:BrandMember srt:NorthAmericaMember 2025-01-01 2025-09-30 0000031235 kodk:BrandMember us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember 2024-07-01 2024-09-30 0000031235 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:FilmAndChemicalsMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:AsiaPacificMember 2025-01-01 2025-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember 2025-07-01 2025-09-30 0000031235 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000031235 srt:AsiaPacificMember 2024-07-01 2024-09-30 0000031235 us-gaap:CommonStockMember 2025-08-08 0000031235 kodk:PrintMember srt:NorthAmericaMember 2024-01-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2024-07-01 2024-09-30 0000031235 us-gaap:RetainedEarningsMember 2025-09-30 0000031235 kodk:AllOtherMember srt:NorthAmericaMember 2024-07-01 2024-09-30 0000031235 kodk:AnnuitiesMember kodk:PrintMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 srt:NorthAmericaMember 2025-01-01 2025-09-30 0000031235 2024-01-01 2024-09-30 0000031235 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:US 2025-07-01 2025-09-30 0000031235 kodk:SeriesCPreferredStockExchangeAgreementMember srt:MinimumMember 2024-12-31 0000031235 kodk:BrandMember us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-30 0000031235 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2025-07-01 2025-09-30 0000031235 srt:MinimumMember us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-09-30 0000031235 srt:MaximumMember us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2025-09-30 0000031235 us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 country:US 2024-01-01 2024-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0000031235 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000031235 us-gaap:PreferredStockMember 2024-12-31 0000031235 kodk:SeriesCPreferredStockExchangeAgreementMember srt:MaximumMember 2025-08-08 0000031235 kodk:AnnuitiesMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 kodk:FilmAndChemicalsMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 country:US 2025-01-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember 2024-07-01 2024-09-30 0000031235 kodk:RefinancingTermLoansMember kodk:FivePercentageUnsecuredConvertiblePromissoryNotesDueMayTwentyEightTwoThousandTwentySixMember 2025-09-30 0000031235 kodk:CurrentAssetClassAllocationMember 2024-01-01 2024-12-31 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:US 2024-07-01 2024-09-30 0000031235 us-gaap:SeriesAPreferredStockMember kodk:RepurchaseAndExchangeAgreementMember 2021-02-26 2021-02-26 0000031235 kodk:AdvancedMaterialsAndChemicalsMember country:CA 2025-01-01 2025-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000031235 srt:LatinAmericaMember 2025-07-01 2025-09-30 0000031235 kodk:EquipmentAndSoftwareMember kodk:PrintMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 us-gaap:EMEAMember 2024-01-01 2024-09-30 0000031235 2022-12-31 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:LatinAmericaMember 2025-01-01 2025-09-30 0000031235 us-gaap:ProductMember 2025-07-01 2025-09-30 0000031235 kodk:PrintMember srt:AsiaPacificMember 2024-07-01 2024-09-30 0000031235 srt:LatinAmericaMember 2024-01-01 2024-09-30 0000031235 us-gaap:ForeignPlanMember 2024-07-01 2024-09-30 0000031235 2024-03-31 0000031235 us-gaap:PensionPlansDefinedBenefitMember country:US 2024-01-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:OngoingServiceArrangementsMember 2024-01-01 2024-09-30 0000031235 2025-07-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:EMEAMember 2024-07-01 2024-09-30 0000031235 country:US 2025-09-30 0000031235 kodk:AllOtherMember country:US 2024-07-01 2024-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AllOtherMember 2025-07-01 2025-09-30 0000031235 kodk:EquipmentAndSoftwareMember kodk:PrintMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 us-gaap:RetainedEarningsMember 2025-03-31 0000031235 2025-01-01 2025-03-31 0000031235 us-gaap:PensionPlansDefinedBenefitMember country:US 2024-07-01 2024-09-30 0000031235 kodk:BrandMember 2024-01-01 2024-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2023-12-31 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:OngoingServiceArrangementsMember 2024-07-01 2024-09-30 0000031235 us-gaap:SeriesCPreferredStockMember kodk:PurchaseAgreementMember 2021-02-26 2021-02-26 0000031235 us-gaap:NonUsMember 2024-12-31 0000031235 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0000031235 kodk:SeriesCPreferredStockExchangeAgreementMember 2025-01-01 2025-09-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000031235 country:US 2025-07-01 2025-09-30 0000031235 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000031235 kodk:RepurchaseAndExchangeAgreementMember us-gaap:SeriesBPreferredStockMember 2021-02-26 2021-02-26 0000031235 us-gaap:PreferredStockMember 2024-09-30 0000031235 kodk:LCFacilityAgreementMember 2023-07-01 2023-12-31 0000031235 kodk:BrandMember kodk:OtherMember 2024-07-01 2024-09-30 0000031235 kodk:AnnuitiesMember kodk:PrintMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 us-gaap:RetainedEarningsMember 2025-06-30 0000031235 kodk:PrintMember country:US 2025-01-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember 2024-01-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:EMEAMember 2025-07-01 2025-09-30 0000031235 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember kodk:PrintMember 2024-07-01 2024-09-30 0000031235 srt:MaximumMember 2024-07-01 2024-09-30 0000031235 srt:AsiaPacificMember 2024-01-01 2024-09-30 0000031235 us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2025-01-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2024-01-01 2024-09-30 0000031235 srt:MaximumMember 2025-01-01 2025-09-30 0000031235 srt:LatinAmericaMember 2025-01-01 2025-09-30 0000031235 kodk:AllOtherMember kodk:OtherMember 2025-07-01 2025-09-30 0000031235 2025-09-30 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:GrowthProductsMember 2024-01-01 2024-09-30 0000031235 kodk:AmendedABLCreditAgreementMember 2022-12-31 0000031235 us-gaap:PreferredStockMember 2025-03-31 0000031235 us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember 2024-07-01 2024-09-30 0000031235 kodk:LCFacilityAgreementMember 2024-12-31 0000031235 us-gaap:SegmentContinuingOperationsMember kodk:AdvancedMaterialsAndChemicalsMember us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-30 0000031235 us-gaap:EMEAMember 2025-09-30 0000031235 kodk:AllOtherMember 2024-01-01 2024-09-30 0000031235 country:CA 2024-07-01 2024-09-30 0000031235 us-gaap:ProductMember 2024-01-01 2024-09-30 0000031235 2023-12-31 0000031235 2025-03-31 2025-03-31 0000031235 kodk:RefinancingTermLoansMember srt:MaximumMember 2025-09-30 0000031235 us-gaap:EMEAMember 2024-12-31 0000031235 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000031235 kodk:BrandMember 2025-01-01 2025-09-30 0000031235 kodk:TerminationChangesMember 2025-09-30 2025-09-30 0000031235 kodk:SeriesCPreferredStockExchangeAgreementMember srt:MinimumMember 2025-01-01 2025-09-30 0000031235 kodk:BrandMember country:US 2024-01-01 2024-09-30 0000031235 kodk:KodakRetirementIncomePlanMember us-gaap:SubsequentEventMember kodk:MissingParticipantsMember 2025-11-30 0000031235 us-gaap:TreasuryStockCommonMember 2025-06-30 0000031235 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000031235 kodk:ExtendedWarrantyArrangementsMember 2025-09-30 0000031235 kodk:BrandMember us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember 2025-01-01 2025-09-30 0000031235 kodk:LCFacilityAgreementMember 2023-07-21 2023-07-21 0000031235 kodk:TermLoanCreditAgreementMember 2025-09-30 0000031235 kodk:AnnuitiesMember kodk:PrintMember us-gaap:CoreMember 2025-01-01 2025-09-30 0000031235 us-gaap:SeriesBPreferredStockMember 2021-02-26 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:NorthAmericaMember 2024-01-01 2024-09-30 0000031235 us-gaap:PreferredStockMember 2023-12-31 0000031235 kodk:AllOtherMember 2025-07-01 2025-09-30 0000031235 us-gaap:CommonStockMember 2025-09-30 0000031235 kodk:BrandMember 2025-07-01 2025-09-30 0000031235 kodk:KRIPsProjectedBenefitObligationPBOMember 2025-03-31 2025-03-31 0000031235 kodk:OtherMember 2025-01-01 2025-09-30 0000031235 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember srt:NorthAmericaMember 2024-07-01 2024-09-30 0000031235 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000031235 country:BR kodk:FederalAndStateValueAddedTaxesLitigationsAndCivilLitigationAndDisputesWithFormerEmployeesMember 2025-09-30 0000031235 kodk:FilmAndChemicalsMember us-gaap:CoreMember 2025-07-01 2025-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2025-07-01 2025-09-30 0000031235 kodk:LCFacilityAgreementMember 2023-08-01 2023-08-31 0000031235 kodk:AdvancedMaterialsAndChemicalsMember kodk:GrowthProductsMember 2024-07-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember 2025-01-01 2025-09-30 0000031235 kodk:LetterOfCreditFacilityAgreementMember 2022-12-31 0000031235 us-gaap:SeriesCPreferredStockMember 2025-09-30 0000031235 us-gaap:EMEAMember 2025-01-01 2025-09-30 0000031235 kodk:KodakRetirementIncomePlanMember us-gaap:SubsequentEventMember 2025-10-21 2025-10-21 0000031235 kodk:PrintMember srt:AsiaPacificMember 2024-01-01 2024-09-30 0000031235 kodk:AdvancedMaterialsAndChemicalsMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2025-01-01 2025-09-30 0000031235 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0000031235 2025-06-30 0000031235 srt:MaximumMember us-gaap:SeriesBPreferredStockMember 2024-12-31 0000031235 us-gaap:SegmentContinuingOperationsMember 2025-01-01 2025-09-30 0000031235 kodk:PrintMember us-gaap:CoreMember kodk:PlatesInksAndOtherConsumablesMember 2025-01-01 2025-09-30 utr:acre xbrli:pure iso4217:USD xbrli:shares xbrli:shares kodk:Days kodk:Segment kodk:ParticipantsAndBeneficiaries iso4217:USD

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended: September 30, 2025

or

☐ | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to

Commission File Number

1-00087

EASTMAN KODAK COMPANY

(Exact name of Registrant as specified in its charter)

New Jersey | 16-0417150
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.)
343 STATE STREET, ROCHESTER, New York | 14650
(Address of principal executive offices) | (Zip Code)

(800) 356-3259

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Common |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common stock, par value $0.01 per share |  | KODK |  | New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth" company in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☐ |  | Accelerated filer | ☒ |
Non-accelerated filer |  | ☐ |  | Smaller reporting company | ☐ |
Emerging growth company |  | ☐ |  |  |  |

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 31, 2025, the Registrant had 96.4 million shares of common stock, par value $0.01 per share, outstanding.

Table of Contents

EASTMAN KODAK COMPANY

Form 10-Q

September 30, 2025

|  | Page
| Part I.—Financial Information |
Item 1. | Financial Statements | 2
| Consolidated Statement of Operations (Unaudited) | 2
| Consolidated Statement of Comprehensive Income (Unaudited) | 3
| Consolidated Statement of Financial Position (Unaudited) | 4
| Consolidated Statement of Cash Flows (Unaudited) | 5
| Consolidated Statement of Equity (Deficit) (Unaudited) | 6
| Notes to Financial Statements (Unaudited) | 8
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 33
| Liquidity and Capital Resources | 43
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 47
Item 4. | Controls and Procedures | 47
| Part II. —Other Information |
Item 1. | Legal Proceedings | 49
Item 1A. | Risk Factors | 49
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 49
Item 3. | Defaults Upon Senior Securities | 49
Item 4. | Mine Safety Disclosures | 49
Item 5. | Other Information | 49
Item 6. | Exhibits | 50
| Index to Exhibits | 50
| Signatures | 52

1

Table of Contents

Part I. FINANCIAL INFORMATION

Item 1. Financial Statements

EASTMAN KODAK COMPANY

C ONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions, except per share data) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
Sales |  | $ | 229 |  |  | $ | 221 |  |  | $ | 665 |  |  | $ | 654 |
Services |  |  | 40 |  |  |  | 40 |  |  |  | 114 |  |  |  | 123 |
Total revenues |  |  | 269 |  |  |  | 261 |  |  |  | 779 |  |  |  | 777 |
Cost of revenues |  |  |  |  |  |  |  |  |  |  |  |
Sales |  |  | 174 |  |  |  | 185 |  |  |  | 532 |  |  |  | 534 |
Services |  |  | 27 |  |  |  | 31 |  |  |  | 82 |  |  |  | 91 |
Total cost of revenues |  |  | 201 |  |  |  | 216 |  |  |  | 614 |  |  |  | 625 |
Gross profit |  |  | 68 |  |  |  | 45 |  |  |  | 165 |  |  |  | 152 |
Selling, general and administrative expenses |  |  | 41 |  |  |  | 44 |  |  |  | 127 |  |  |  | 136 |
Research and development costs |  |  | 7 |  |  |  | 8 |  |  |  | 25 |  |  |  | 25 |
Restructuring costs and other |  |  | 1 |  |  |  | 1 |  |  |  | 12 |  |  |  | 6 |
Other operating income, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (16 | )
Earnings (loss) from operations before interest expense, pension income excluding service cost component, other charges (income), net and income taxes |  |  | 19 |  |  |  | (8 | ) |  |  | 1 |  |  |  | 1 |
Interest expense |  |  | 18 |  |  |  | 14 |  |  |  | 47 |  |  |  | 44 |
Pension income excluding service cost component |  |  | (16 | ) |  |  | (42 | ) |  |  | (54 | ) |  |  | (124 | )
Other charges (income), net |  |  | 1 |  |  |  | (1 | ) |  |  | 21 |  |  |  | (2 | )
Earnings (loss) from operations before income taxes |  |  | 16 |  |  |  | 21 |  |  |  | (13 | ) |  |  | 83 |
Provision for income taxes |  |  | 3 |  |  |  | 3 |  |  |  | 7 |  |  |  | 7 |
NET EARNINGS (LOSS) |  | $ | 13 |  |  | $ | 18 |  |  | $ | (20 | ) |  | $ | 76 |
Basic net (loss) earnings per share attributable to Eastman Kodak Company common shareholders |  | $ | (0.08 | ) |  | $ | 0.16 |  |  | $ | (0.55 | ) |  | $ | 0.73 |
Diluted net (loss) earnings per share attributable to Eastman Kodak Company common shareholders |  | $ | (0.08 | ) |  | $ | 0.15 |  |  | $ | (0.55 | ) |  | $ | 0.67 |
Number of common shares used in basic and diluted net (loss) earnings per share |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 89.8 |  |  |  | 80.3 |  |  |  | 83.8 |  |  |  | 80.0 |
Diluted |  |  | 89.8 |  |  |  | 92.7 |  |  |  | 83.8 |  |  |  | 92.1 |

The accompanying notes are an integral part of these consolidated financial statements.

2

Table of Contents

EASTMAN KODAK COMPANY

C ONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
NET EARNINGS (LOSS) |  | $ | 13 |  |  | $ | 18 |  |  | $ | (20 | ) |  | $ | 76 |
Other comprehensive (loss) income, net of tax: |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  |  | (2 | ) |  |  | 12 |  |  |  | 11 |  |  |  | — |
Pension and other postretirement benefit plan obligation activity, net of tax |  |  | 98 |  |  |  | (7 | ) |  |  | 10 |  |  |  | (20 | )
Other comprehensive income (loss), net of tax |  |  | 96 |  |  |  | 5 |  |  |  | 21 |  |  |  | (20 | )
COMPREHENSIVE INCOME, NET OF TAX |  | $ | 109 |  |  | $ | 23 |  |  | $ | 1 |  |  | $ | 56 |

The accompanying notes are an integral part of these consolidated financial statements.

3

Table of Contents

EASTMAN KODAK COMPANY

C ONSOLIDATED STATEMENT OF FINANCIAL POSITION (Unaudited)

|  | September 30, |  |  | December 31, |
(in millions, except per share data) |  | 2025 |  |  | 2024 |
ASSETS |  |  |  |  |  |
Cash and cash equivalents |  | $ | 168 |  |  | $ | 201 |
Trade receivables, net of allowances of $8 and $7, respectively |  |  | 146 |  |  |  | 138 |
Inventories, net |  |  | 236 |  |  |  | 219 |
Other current assets |  |  | 42 |  |  |  | 37 |
Total current assets |  |  | 592 |  |  |  | 595 |
Property, plant and equipment, net of accumulated depreciation of $492 and $482, respectively |  |  | 198 |  |  |  | 189 |
Goodwill |  |  | 12 |  |  |  | 12 |
Intangible assets, net |  |  | 17 |  |  |  | 20 |
Operating lease right-of-use assets |  |  | 37 |  |  |  | 27 |
Restricted cash |  |  | 95 |  |  |  | 92 |
Pension and other postretirement assets |  |  | 1,054 |  |  |  | 989 |
Other long-term assets |  |  | 70 |  |  |  | 77 |
TOTAL ASSETS |  | $ | 2,075 |  |  | $ | 2,001 |
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY |  |  |  |  |  |
Accounts payable, trade |  | $ | 103 |  |  | $ | 120 |
Short-term borrowings and current portion of long-term debt |  |  | 497 |  |  |  | 1 |
Current portion of operating leases |  |  | 12 |  |  |  | 11 |
Other current liabilities |  |  | 137 |  |  |  | 129 |
Total current liabilities |  |  | 749 |  |  |  | 261 |
Long-term debt, net of current portion |  |  | 10 |  |  |  | 466 |
Pension and other postretirement liabilities |  |  | 216 |  |  |  | 197 |
Operating leases, net of current portion |  |  | 30 |  |  |  | 21 |
Other long-term liabilities |  |  | 209 |  |  |  | 197 |
Total liabilities |  |  | 1,214 |  |  |  | 1,142 |
Commitments and Contingencies (Note 7) |  |  |  |  |  |
Redeemable, convertible preferred stock, no par value, $100 per share liquidation preference |  |  | 99 |  |  |  | 218 |
EQUITY |  |  |  |  |  |
Common stock, $0.01 par value |  |  | 1 |  |  |  | — |
Additional paid in capital |  |  | 1,271 |  |  |  | 1,150 |
Treasury stock, at cost |  |  | (14 | ) |  |  | (12 | )
Accumulated deficit |  |  | (413 | ) |  |  | (393 | )
Accumulated other comprehensive loss |  |  | (83 | ) |  |  | (104 | )
Total shareholders’ equity |  |  | 762 |  |  |  | 641 |
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY |  | $ | 2,075 |  |  | $ | 2,001 |

The accompanying notes are an integral part of these consolidated financial statements.

4

Table of Contents

EASTMAN KODAK COMPANY

C ONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

|  | Nine Months Ended |
|  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |
Cash flows from operating activities: |  |  |  |  |  |
Net (loss) earnings |  | $ | (20 | ) |  | $ | 76 |
Adjustments to reconcile to net cash used in operating activities: |  |  |  |  |  |
Depreciation and amortization |  |  | 21 |  |  |  | 21 |
Pension and postretirement income |  |  | (42 | ) |  |  | (111 | )
Asset impairment |  |  | 21 |  |  |  | — |
Paid-in-kind interest expense |  |  | 36 |  |  |  | 17 |
Non-cash changes in workers' compensation and employee benefit reserves |  |  | — |  |  |  | 1 |
Stock based compensation |  |  | 4 |  |  |  | 5 |
Net gain from sale of assets |  |  | — |  |  |  | (17 | )
Provision for deferred income taxes |  |  | 1 |  |  |  | — |
Decrease in trade receivables |  |  | — |  |  |  | 52 |
Decrease (increase) in miscellaneous receivables |  |  | 2 |  |  |  | (6 | )
Increase in inventories |  |  | (12 | ) |  |  | (25 | )
Decrease in trade payables |  |  | (15 | ) |  |  | (1 | )
Decrease in liabilities excluding borrowings and trade payables |  |  | (22 | ) |  |  | (39 | )
Other items, net |  |  | 17 |  |  |  | 16 |
Total adjustments |  |  | 11 |  |  |  | (87 | )
Net cash used in operating activities |  |  | (9 | ) |  |  | (11 | )
Cash flows from investing activities: |  |  |  |  |  |
Additions to properties |  |  | (28 | ) |  |  | (39 | )
Proceeds from sale of assets |  |  | 5 |  |  |  | 17 |
Net cash used in investing activities |  |  | (23 | ) |  |  | (22 | )
Cash flows from financing activities: |  |  |  |  |  |
Net proceeds from ATM equity offering program |  | 1 |  |  |  | — |
Repayment of Amended and Restated Term Loan Agreement |  |  | — |  |  |  | (17 | )
Preferred stock cash dividend payments |  |  | (2 | ) |  |  | (3 | )
Treasury stock purchases |  |  | (2 | ) |  |  | (1 | )
Net cash used in financing activities |  |  | (3 | ) |  |  | (21 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  |  | 5 |  |  |  | (1 | )
Net decrease in cash, cash equivalents and restricted cash |  |  | (30 | ) |  |  | (55 | )
Cash, cash equivalents and restricted cash, beginning of period |  |  | 301 |  |  |  | 377 |
Cash, cash equivalents and restricted cash, end of period |  | $ | 271 |  |  | $ | 322 |
Non-cash financing activities: |  |  |  |  |  |
Series C preferred stock exchange to common stock |  | $ | 124 |  |  | $ | — |

The accompanying notes are an integral part of these consolidated financial statements.

5

Table of Contents

EASTMAN KODAK COMPANY

C ONSOLIDATED STATEMENT OF EQUITY (DEFICIT) (Unaudited)

|  | Nine-Month Period Ending September 30, 2025 |
|  | Eastman Kodak Company Common Shareholders |  |  |  |
(in millions) |  | Common Stock |  |  | Additional Paid in Capital |  |  | Accumulated Deficit |  |  | Accumulated Other Comprehensive Loss |  |  | Treasury Stock |  |  | Total |  |  | Redeemable Convertible Preferred Stock |
Equity (deficit) as of December 31, 2024 |  | $ | — |  |  | $ | 1,150 |  |  | $ | (393 | ) |  | $ | (104 | ) |  | $ | (12 | ) |  | $ | 641 |  |  | $ | 218 |
Net loss |  |  | — |  |  |  | — |  |  |  | (7 | ) |  |  | — |  |  |  | — |  |  |  | (7 | ) |  |  | — |
Other comprehensive income (loss) (net of tax): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 6 |  |  |  | — |  |  |  | 6 |  |  |  | — |
Pension and other postretirement liability adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (75 | ) |  |  | — |  |  |  | (75 | ) |  |  | — |
Preferred stock cash dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |
Preferred stock in-kind dividends |  |  | — |  |  |  | (2 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2 | ) |  |  | 2 |
Purchases of treasury stock (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | (1 | ) |  |  | — |
Stock-based compensation |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2 |  |  |  | — |
Equity (deficit) as of March 31, 2025 |  | $ | — |  |  | $ | 1,149 |  |  | $ | (400 | ) |  | $ | (173 | ) |  | $ | (13 | ) |  | $ | 563 |  |  | $ | 220 |
Net loss |  |  | — |  |  |  | — |  |  |  | (26 | ) |  |  | — |  |  |  | — |  |  |  | (26 | ) |  |  | — |
Other comprehensive income (loss) (net of tax): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 7 |  |  |  | — |  |  |  | 7 |  |  |  | — |
Pension and other postretirement liability adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (13 | ) |  |  | — |  |  |  | (13 | ) |  |  | — |
Preferred stock accrued cash dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |
Preferred stock in-kind dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | 1 |
Preferred stock deemed dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | 1 |
Purchases of treasury stock (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | (1 | ) |  |  | — |
Stock-based compensation |  |  | — |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | — |
Equity (deficit) as of June 30, 2025 |  | $ | — |  |  | $ | 1,147 |  |  | $ | (426 | ) |  | $ | (179 | ) |  | $ | (14 | ) |  | $ | 528 |  |  | $ | 222 |
Net earnings |  |  | — |  |  |  | — |  |  |  | 13 |  |  |  | — |  |  |  | — |  |  |  | 13 |  |  |  |
Other comprehensive (loss) income (net of tax): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2 | ) |  |  | — |  |  |  | (2 | ) |  |  | — |
Pension and other postretirement liability adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 98 |  |  |  | — |  |  |  | 98 |  |  |  | — |
Common shares issued under ATM equity offering program |  |  |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | — |
Preferred stock accrued cash dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |
Series C preferred stock exchange for common stock |  |  | 1 |  |  |  | 123 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 124 |  |  |  | (123 | )
Stock-based compensation |  |  | — |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | — |
Equity (deficit) as of September 30, 2025 |  | $ | 1 |  |  | $ | 1,271 |  |  | $ | (413 | ) |  | $ | (83 | ) |  | $ | (14 | ) |  | $ | 762 |  |  | $ | 99 |

6

Table of Contents

|  | Nine-Month Period Ending September 30, 2024 |
|  | Eastman Kodak Company Common Shareholders |  |  |  |
(in millions) |  | Common Stock |  |  | Additional Paid in Capital |  |  | Accumulated Deficit |  |  | Accumulated Other Comprehensive Income |  |  | Treasury Stock |  |  | Total |  |  | Redeemable Convertible Preferred Stock |
Equity (deficit) as of December 31, 2023 |  | $ | — |  |  | $ | 1,156 |  |  | $ | (495 | ) |  | $ | 281 |  |  | $ | (11 | ) |  | $ | 931 |  |  | $ | 210 |
Net earnings |  |  | — |  |  |  | — |  |  |  | 32 |  |  |  | — |  |  |  | — |  |  |  | 32 |  |  |  | — |
Other comprehensive loss (net of tax): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | — |  |  |  | (6 | ) |  |  | — |
Pension and other postretirement liability adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | — |  |  |  | (6 | ) |  |  | — |
Preferred stock cash dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |
Preferred stock in-kind dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | 1 |
Preferred stock deemed dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | 1 |
Stock-based compensation |  |  | — |  |  |  | 3 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3 |  |  |  | — |
Equity (deficit) as of March 31, 2024 |  | $ | — |  |  | $ | 1,156 |  |  | $ | (463 | ) |  | $ | 269 |  |  | $ | (11 | ) |  | $ | 951 |  |  | $ | 212 |
Net earnings |  |  | — |  |  |  | — |  |  |  | 26 |  |  |  | — |  |  |  | — |  |  |  | 26 |  |  |  | — |
Other comprehensive loss (net of tax): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | — |  |  |  | (6 | ) |  |  | — |
Pension and other postretirement liability adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7 | ) |  |  | — |  |  |  | (7 | ) |  |  | — |
Preferred stock cash dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |
Preferred stock in-kind dividends |  |  | — |  |  |  | (2 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2 | ) |  |  | 2 |
Purchases of treasury stock (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | (1 | ) |  |  | — |
Stock-based compensation |  |  | — |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | — |
Equity (deficit) as of June 30, 2024 |  | $ | — |  |  | $ | 1,154 |  |  | $ | (437 | ) |  | $ | 256 |  |  | $ | (12 | ) |  | $ | 961 |  |  | $ | 214 |
Net earnings |  |  | — |  |  |  | — |  |  |  | 18 |  |  |  | — |  |  |  | — |  |  |  | 18 |  |  |  | — |
Other comprehensive income (loss) (net of tax): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 12 |  |  |  | — |  |  |  | 12 |  |  |  | — |
Pension and other postretirement liability adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7 | ) |  |  | — |  |  |  | (7 | ) |  |  | — |
Preferred stock cash dividends |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |
Preferred stock in-kind dividends |  |  | — |  |  |  | (2 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2 | ) |  |  | 2 |
Stock-based compensation |  |  | — |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | — |
Equity (deficit) as of September 30, 2024 |  | $ | — |  |  | $ | 1,152 |  |  | $ | (419 | ) |  | $ | 261 |  |  | $ | (12 | ) |  | $ | 982 |  |  | $ | 216 |

(1) Represents purchases of common stock to satisfy tax withholding obligations.

The accompanying notes are an integral part of these consolidated financial statements.

7

Table of Contents

EASTMAN KODAK COMPANY

N OTES TO FINANCIAL STATEMENTS (Unaudited)

NOTE 1: BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS

BASIS OF PRESENTATION

The consolidated interim financial statements are unaudited, and certain information and footnote disclosures related thereto normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying unaudited consolidated interim financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results of operations, financial position and cash flows of Eastman Kodak Company and all companies directly or indirectly controlled, either through majority ownership or otherwise (“Kodak” or the “Company”). The results of operations for the interim periods are not necessarily indicative of the results for the entire fiscal year. These consolidated interim statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”).

RECLASSIFICATIONS

Certain amounts from previous periods have been reclassified to conform to the current period classification of paid-in-kind interest expense in the Consolidated Statement of Cash Flows.

GOING CONCERN

As disclosed in the Company’s quarterly report on Form 10‐Q for the quarter ended June 30, 2025, Kodak had debt coming due within twelve months and its plans to adequately fund its debt obligations at that time were not solely within the Company’s control and therefore were not deemed “probable” under U.S. GAAP.

As of the date of issuance of these consolidated interim financial statements, the Company has extended the maturity dates of the Term Loans (defined below) and the L/C Facility Agreement (defined below). In addition, as of the date of issuance of these consolidated interim financial statements, Kodak has settled approximately $2.1 billion of pension obligations under the Kodak Retirement Income Plan (“KRIP”) and will transfer the remaining liabilities of approximately $15 million for missing participants to the Pension Benefit Guaranty Corporation (“PBGC”) by the end of November 2025. Upon completing the transfer of these remaining liabilities to the PBGC, all pension obligations under KRIP will be fully settled and the excess pension assets will be distributed to the Company and the Kodak Cash Balance Plan, given the authority of the Plan Sponsor (Kodak) to distribute such assets. Refer to Note 19, “Subsequent Events” for additional information on the amendments for the Term Loans and L/C Facility Agreement as well as the settlement of KRIP’s pension obligations.

Based on the actions completed by management, the Company will receive sufficient proceeds from the reversion of cash from KRIP to the Company in December 2025 to adequately fund the Company’s debt obligations required to be paid from such proceeds or otherwise maturing within twelve months as of the filing of this Form 10-Q. Therefore, the prior conditions that raised substantial doubt about Kodak’s ability to continue as a going concern, as disclosed in the Form 10-Q for the quarter ended June 30, 2025, have been resolved.

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

No accounting pronouncements were recently adopted by Kodak.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires disclosure of additional categories of information about federal, state and foreign income taxes in the rate reconciliation table and more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively. The ASU is effective for Kodak for the fiscal year ending December 31, 2025, and the required disclosures will be included in Kodak's Form 10-K for the year ending December 31, 2025. As

8

Table of Contents

the requirements of this ASU relate to disclosure only, the adoption of this ASU will not have a material impact on Kodak’s consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. ASU 2024-03 requires public business entities to disclose specified information about certain costs and expenses, including but not limited to purchases of inventory, employee compensation, depreciation, and intangible asset amortization, in a tabular format within the notes to their financial statements, as well as provide additional disclosures related to certain other specified expenses. The ASU may be applied on either a prospective or retrospective basis and is effective for annual reporting periods beginning after December 15, 2026 (January 1, 2027 for Kodak) and interim reporting periods beginning after December 15, 2027 (January 1, 2028 for Kodak). As the requirements of this ASU relate to disclosure only, the adoption of this ASU will not have a material impact on Kodak’s consolidated financial statements.

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 modernizes the accounting for internal-use software to reflect the evolution of software development to using an incremental and iterative development method. Accordingly, the ASU removes all references in Subtopic 350-40 to prescriptive and sequential software development phases (or “project stages”), and requires an entity to start capitalizing software costs when both (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed and the software will be used to perform the function intended. The ASU may be applied using either a prospective, retrospective, or modified transition approach, and is effective for annual reporting periods beginning after December 15, 2027 and interim reporting periods within such annual reporting periods (January 1, 2028 for Kodak). The Company is currently evaluating the impact of this ASU.

NOTE 2: CASH, CASH EQUIVALENTS AND RESTRICTED CASH

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Statement of Financial Position that sums to the total of such amounts shown in the Consolidated Statement of Cash Flows:

|  | September 30, |  |  | December 31, |
(in millions) |  | 2025 |  |  | 2024 |
Cash and cash equivalents |  | $ | 168 |  |  | $ | 201 |
Restricted cash reported in Other current assets |  |  | 8 |  |  |  | 8 |
Restricted cash |  |  | 95 |  |  |  | 92 |
Total cash, cash equivalents and restricted cash shown in the Consolidated Statement of Cash Flows |  | $ | 271 |  |  | $ | 301 |

Restricted cash reported in Other current assets on the Consolidated Statement of Financial Position primarily represented amounts that support hedging activities as of September 30, 2025 and December 31, 2024.

Restricted cash included $25 million and $29 million as of September 30, 2025 and December 31, 2024, respectively, representing the cash collateral required to be posted by the Company under the Amended and Restated L/C Facility Agreement, defined below. In addition, restricted cash as of September 30, 2025 and December 31, 2024 included $61 million and $55 million, respectively, primarily representing cash collateral supporting the Company’s undiscounted actuarial workers’ compensation obligations with the New York State Workers’ Compensation Board ("NYS WCB"). Restricted cash also included $7 million and $6 million of security posted related to Brazilian legal contingencies as of September 30, 2025 and December 31, 2024, respectively.

NOTE 3: INVENTORIES, NET

|  | September 30, |  |  | December 31, |
(in millions) |  | 2025 |  |  | 2024 |
Finished goods |  | $ | 95 |  |  | $ | 90 |
Work in process |  |  | 77 |  |  |  | 69 |
Raw materials |  |  | 64 |  |  |  | 60 |
Total |  | $ | 236 |  |  | $ | 219 |

9

Table of Contents

NOTE 4: DEBT AND CREDIT FACILITIES

Term Loan Credit Agreement

On February 26, 2021, the Company and certain of its subsidiaries (the "Subsidiary Guarantors") entered into a Credit Agreement (the “Original Term Loan Credit Agreement”) with certain funds affiliated with Kennedy Lewis Investment Management LLC (“KLIM”) as lenders (the “Original Term Loan Lenders”) and Alter Domus (US) LLC, as administrative agent (the “Term Loan Agent”). Pursuant to the Original Term Loan Credit Agreement, the Original Term Loan Lenders provided the Company with (i) an initial term loan in the amount of $225 million, which was drawn in full on the same date, and (ii) a commitment to provide delayed draw term loans in an aggregate principal amount of up to $50 million on or before February 26, 2023 (collectively, the “Original Term Loans”). The delayed draw term loans were drawn in full on June 15, 2022. The maturity date of the Original Term Loans was February 26, 2026, and the Original Term Loans were non-amortizing.

On June 30, 2023, the Company and the Subsidiary Guarantors entered into an amendment (the “Term Loan Amendment”) to the Original Term Loan Credit Agreement (the Original Term Loan Credit Agreement, as amended and restated the “Amended and Restated Term Loan Credit Agreement”), with certain funds affiliated with KLIM as lenders (the “Term Loan Lenders”) and the Term Loan Agent. Subject to the terms and conditions of the Term Loan Amendment, the Term Loan Lenders provided the Company with a commitment to provide term loans in an aggregate principal amount of $450 million (the “Term Loans”).

On July 21, 2023, the Amended and Restated Term Loan Credit Agreement became effective and the Company completed its borrowing of the Term Loans. The Company received net proceeds of $435 million from the Term Loans which were used to (i) refinance the obligations under the Original Term Loan Credit Agreement, (ii) repay in full and terminate the commitments under the Company’s asset-based revolving credit facility made available pursuant to amendment No. 5 to the Amended and Restated Credit Agreement (the “2023 Amended ABL Credit Agreement") with the lenders party thereto, Bank of America, N.A., as administrative agent and collateral agent, (iii) repay in full the Company’s outstanding 5.0% unsecured convertible promissory notes due May 28, 2026 (the "Convertible Notes") held by the Original Term Loan Lenders, (iv) pay certain fees and expenses related to the foregoing and the Amended and Restated L/C Facility Agreement (as defined below), (v) provide cash collateral in respect of the Amended and Restated L/C Facility Agreement, as described below, or other collateral obligations, and (vi) for general corporate purposes and working capital needs of the Company and its subsidiaries (a net amount of $29 million).

The Term Loan Amendment also amended and restated the Original Term Loan Credit Agreement to, among other things, (i) extend the maturity date to the earlier of August 15, 2028 or the date that is 91 days prior to the maturity date or mandatory redemption date of any of the Company’s then-outstanding Series B Preferred Stock or Series C Preferred Stock ("Convertible Securities") or any extensions or refinancings of any of the foregoing, (ii) make certain other changes to the terms of the Original Term Loan Credit Agreement and (iii) make certain other changes to the terms of the Guarantee and Collateral Agreement, dated as of February 26, 2021, among the Company, the Subsidiary Guarantors and the Term Loan Agent.

The Term Loans bear interest at a rate of 7.5% per annum payable in cash (the “Cash Interest Payment”) and 5.0% per annum payable “in-kind” ("PIK") or in cash at the Company’s option, for an aggregate interest rate of 12.5% per annum. Obligations under the Amended and Restated Term Loan Credit Agreement are secured by a first priority lien on substantially all assets of the Company and the Subsidiary Guarantors (subject to certain exceptions) not constituting L/C Cash Collatera l, as defined below (collectively, the “Term Loan Priority Collateral”), and a second priority lien on the L/C Cash Collateral.

The Amended and Restated Term Loan Credit Agreement continues to limit, among other things, the ability of the Company and its Restricted Subsidiaries (as defined in the Amended and Restated Term Loan Credit Agreement) to (i) incur indebtedness, (ii) incur or create liens, (iii) dispose of assets, (iv) make restricted payments and (v) make investments. The Amended and Restated Term Loan Credit Agreement contains customary affirmative covenants, including delivery of certain of the Company’s financial statements, and customary event of default provisions, including a cross-default provision that would give rise to an event of default if there is a default under or acceleration of “Material Indebtedness” other than intercompany indebtedness. Material Indebtedness includes obligations having a principal amount of at least $20 million (increasing to $25 million if the Term Loans are paid down to $200 million, which is referred to as the “Deleveraging Milestone Date”). The Amended and Restated Term Loan Credit Agreement does not include a financial maintenance covenant or any subjective acceleration clauses.

On February 26, 2025, the Company and the Subsidiary Guarantors entered into the First Amendment to the Amended and Restated Term Loan Credit Agreement (the “February 2025 Term Loan Credit Agreement Amendment”) with the Term Loan Lenders and the Term Loan Agent to modify the maturity date of the Term Loans to the earlier of August 15, 2028 or May 22, 2026, the date that is

10

Table of Contents

five days prior to the maturity date or mandatory redemption date of any of the Company’s then-outstanding Convertible Securities or any extensions or refinancings of any of the foregoing.

On May 7, 2025, the Company and the Subsidiary Guarantors entered into the Second Amendment to the Amended and Restated Term Loan Credit Agreement (the “May 2025 Term Loan Credit Agreement Amendment”). The May 2025 Term Loan Credit Agreement Amendment provides the Company the option to pay the Cash Interest Payment entirely in PIK for the next six quarterly interest payments. In addition, the May 2025 Term Loan Credit Agreement Amendment revises the mandatory prepayment provisions under the Amended and Restated Term Loan Credit Agreement requiring Kodak to use 100% of the net cash proceeds from certain transactions to prepay Term Loans until the amount of the Term Loans is reduced to $200 million and, thereafter, to use 50% of the net cash proceeds to prepay Term Loans until the amount of the Term Loans is reduced to $100 million, in each case plus a 1% prepayment fee. The Company elected to pay the Cash Interest Payment for the second and third quarters of 2025 entirely in PIK.

On November 4, 2025, the Company and the Subsidiary Guarantors entered into the Third Amendment to the Amended and Restated Credit Agreement with the Term Loan Lenders and the Term Loan Agent which, among other things, modified the maturity date of the Term Loans. Refer to Note 19, “Subsequent Events” for additional information.

Letter of Credit Facility Agreement

On February 26, 2021, the Company and the Subsidiary Guarantors entered into a Letter of Credit Facility Agreement (the “L/C Facility Agreement”) among the Company, the Subsidiary Guarantors, the lenders party thereto (the “L/C Lenders”), Bank of America, N.A., as agent, and Bank of America, N.A., as issuing bank. Pursuant to the L/C Facility Agreement, the L/C Lenders committed to issue letters of credit on the Company’s behalf in an aggregate amount of up to $50 million, provided that the Company posts cash collateral in an amount greater than or equal to 103% of the aggregate amount of letters of credit issued and outstanding at any given time (the “L/C Cash Collateral”).

On March 14, 2023, the Company entered into an amendment to the L/C Facility Agreement (the “2023 Amended L/C Facility Agreement”) to, among other things: (i) extend the maturity date of the L/C Facility Agreement from February 26, 2024 to the earliest of June 12, 2024, the termination of the 2023 Amended ABL Credit Agreement, as applicable, or the date that is 91 days prior to the earliest scheduled maturity date or mandatory redemption date of any of the Company’s Term Loans, Convertible Notes, Series B Preferred Stock, Series C Preferred Stock or any refinancing of any of the foregoing and (ii) require the Company to maintain daily Minimum Liquidity of $50 million, subject to certain cure rights, and to maintaining a quarterly Minimum Liquidity of $80 million. Each of the capitalized but undefined terms used in the context of describing the 2023 Amended L/C Facility Agreement has the meaning ascribed to such term in the 2023 Amended L/C Facility Agreement.

The 2023 Amended L/C Facility Agreement required the Company to maintain Excess Availability above the greater of 12.5% of lender commitments or $11.25 million. If Excess Availability fell below the greater of 12.5% of lender commitments or $11.25 million, a Fixed Charge Coverage Ratio Trigger Event would have occurred under the 2023 Amended L/C Facility Agreement. During any Fixed Charge Coverage Ratio Trigger Event, the Company would have been required to maintain a Fixed Charge Coverage Ratio of greater than or equal to 1.0 to 1.0. Since Excess Availability was greater than 12.5% of lender commitments or $11.25 million throughout the term of the 2023 Amended L/C Facility Agreement, Kodak was not required to have a minimum Fixed Charge Coverage Ratio of greater than or equal to 1.0 to 1.0.

On June 30, 2023, the Company and the Subsidiary Guarantors entered into an amendment (the “June 2023 L/C Facility Amendment”) to the 2023 Amended L/C Facility Agreement (as amended and restated by the June 2023 L/C Facility Amendment, the “Amended and Restated L/C Facility Agreement”), with Bank of America, N.A., as L/C Lender, L/C Agent and Issuing Bank. The June 2023 L/C Facility Amendment became effective on July 21, 2023.

Under the terms and conditions of the June 2023 L/C Facility Amendment, the L/C Lender increased the commitment to issue letters of credit on the Company’s behalf from an aggregate amount of up to $50 million, to an aggregate amount of up to $100 million (the “L/C Facility Commitments”), until August 30, 2023; provided that, at all times, the Company posted cash collateral in an amount greater than or equal to 104% of the aggregate amount of letters of credit issued and outstanding at any given time (the “L/C Cash Collateral”).

Upon the termination of the 2023 Amended ABL Credit Agreement on July 21, 2023, the letters of credit totaling $58 million issued under the 2023 Amended ABL Credit Agreement were transferred to the Amended and Restated L/C Facility Agreement. The Company used $59 million of the net proceeds from the Term Loans to cash collateralize the letters of credit transferred to the L/C Facility. In August 2023, the Company used $68 million of the funds in the L/C Cash Collateral account to cash collateralize the

11

Table of Contents

Company’s undiscounted actuarial workers’ compensation obligations directly with the NYS WCB, reducing the issued letters of credit to $31 million, and elected to reduce the L/C Facility Commitments to $50 million effective August 15, 2023.

The June 2023 L/C Facility Amendment also amended and restated the 2023 Amended L/C Facility Agreement to, among other things, (i) extended the maturity date to the earliest of (x) the fifth anniversary of the Restatement Date (as defined therein), (y) the date that is 90 days prior to the maturity of the Amended and Restated Term Loan Credit Agreement, as such date may be extended pursuant to the terms thereof (or the maturity date of any refinancing thereof), or (z) the date that is 90 days prior to the earliest scheduled maturity date or mandatory redemption date of any of the Company’s then-outstanding Convertible Securities or any refinancings of any of the foregoing, (ii) eliminated the existing cash maintenance requirements, and (iii) made certain other changes to the terms of the 2023 Amended L/C Facility Agreement.

Approximately $24 million and $27 million letters of credit were issued under the Amended and Restated L/C Facility Agreement as of September 30, 2025 and December 31, 2024, respectively. The balance on deposit in the L/C Cash Collateral account as of September 30, 2025 and December 31, 2024 was approximately $25 million and $29 million, respectively.

The Company’s obligations under the Amended and Restated L/C Facility Agreement are guaranteed by the Subsidiary Guarantors and are secured by (i) a first priority lien on the L/C Cash Collateral and (ii) a second priority lien on certain Term Loan Priority Collateral of the Company and U.S. subsidiary guarantors.

The Amended and Restated L/C Facility Agreement contains certain affirmative and negative covenants similar to the affirmative and negative covenants contained in the Amended and Restated Term Loan Credit Agreement. The Amended and Restated L/C Facility Agreement does not include a minimum liquidity or financial maintenance covenant.

The Company will pay an unused line fee of 37.5-50 basis points per annum, depending on whether the unused portion of the maximum commitments is less than or equal to 50% or greater than 50% of such commitments, respectively. The Company will pay a letter of credit fee of 3.75% per annum on issued and outstanding letters of credit, in addition to a fronting fee of 25 basis points on such letters of credit. Amounts drawn under any letter of credit will be reimbursed from the L/C Cash Collateral. If not so reimbursed, and not otherwise repaid by the Company to the L/C Lender, such amounts will accrue interest, to be paid monthly, at a floating Base Rate (as defined in the Amended and Restated L/C Facility Agreement) plus 2.75% per annum until repaid.

On February 26, 2025, the Company and the Subsidiary Guarantors entered into an amendment to the Amended and Restated L/C Facility Agreement (the “2025 L/C Facility Agreement Amendment”) with the L/C Lenders and Bank of America, N.A. to modify the maturity date of the facility to the earliest of (x) the fifth anniversary of the Restatement Date, (y) May 12, 2026, the date that is 10 days prior to the maturity of the Amended and Restated Term Loan Credit Agreement, as such date may be extended pursuant to the terms thereof, or (z) May 13, 2026, the date that is 15 days prior to the earliest scheduled maturity date or mandatory redemption date of any of the Company’s then-outstanding Convertible Securities. Upon a Permitted Refinancing (as defined therein) of any of the foregoing, the springing maturity date will be 30 days prior to the maturity date or redemption date of the refinancing.

On November 4, 2025, the Company and the Subsidiary Guarantors entered into Amendment No. 4 to the L/C Facility Agreement with the L/C Lenders and Bank of America, N.A. which, among other things, modified the maturity date of the facility. Refer to Note 19, “Subsequent Events” for additional information.

12

Table of Contents

NOTE 5: REDEEMABLE, CONVERTIBLE PREFERRED STOCK

Redeemable convertible preferred stock was as follows:

|  | September 30, |  |  | December 31, |
(in millions) |  | 2025 |  |  | 2024 |
Series B preferred stock |  | $ | 99 |  |  | $ | 98 |
Series C preferred stock |  |  | — |  |  |  | 120 |
Total |  | $ | 99 |  |  | $ | 218 |

Series B Preferred Stock

On February 26, 2021 the Company agreed to exchange one million shares of Series A Preferred Stock held by Southeastern Asset Management, Inc. (“Southeastern”) and Longleaf Partners Small-Cap Fund, C2W Partners Master Fund Limited and Deseret Mutual Pension Trust, which were investment funds managed by Southeastern at the time (such investment funds, collectively, the “Purchasers”), for shares of the Company’s newly created 4.0% Series B Convertible Preferred Stock, no par value (the “Series B Preferred Stock”), on a one-for-one basis plus accrued and unpaid dividends. The fair value of the Series B Preferred Stock at the time of issuance approximated $95 million. The Company has classified the Series B Preferred Stock as temporary equity in the Consolidated Statement of Financial Position. If any shares of Series B Preferred Stock have not been converted prior to May 28, 2026, the Company is required to redeem such shares at $100 per share plus the amount of accrued and unpaid dividends.

Dividend and Other Rights

The Series B Preferred Stock has a liquidation preference of $100 per share, and the holders of Series B Preferred Stock are entitled to cumulative dividends payable quarterly in cash at a rate of 4.0% per annum. Until the second quarter of 2025, all dividends owed on the Series B Preferred Stock were declared and paid when due. No quarterly cash dividends were declared in the second and third quarters of 2025. If dividends on any Series B Preferred Stock are in arrears for six or more consecutive or non-consecutive dividend periods, the holders of the Series B Preferred Stock will be entitled to nominate one director at the next annual shareholder meeting and all subsequent shareholder meetings until all accumulated dividends on such Series B Preferred Stock have been paid or set aside.

Conversion Features

Each share of Series B Preferred Stock is convertible, at the option of each holder at any time, into shares of Common Stock at the initial conversion rate of 9.5238 shares of Common Stock for each share of Series B Preferred Stock (equivalent to an initial conversion price of $10.50 per share of Common Stock). The initial conversion rate and the corresponding conversion price are subject to certain customary anti-dilution adjustments. If a holder elects to convert any shares of Series B Preferred Stock during a specified period in connection with a fundamental change (as defined in the Series B Certificate of Designations), such holder can elect to have the conversion rate adjusted and can elect to receive a cash payment in lieu of shares for a portion of the shares. Such holder will also be entitled to a payment in respect of accumulated dividends. In addition, the Company will have the right to require holders to convert any shares of Series B Preferred Stock in connection with certain reorganization events in which case the conversion rate will be adjusted, subject to certain limitations.

The Company will have the right to cause the mandatory conversion of the Series B Preferred Stock into shares of Common Stock at any time after the initial issuance of the Series B Preferred Stock if the closing price of the Common Stock has equaled or exceeded $14.50 (subject to adjustment in the same manner as the conversion price) for 45 trading days within a period of 60 consecutive trading days.

Embedded Conversion Features

The Company concluded that the Series B Preferred Stock is more akin to a debt-type instrument and that the economic characteristics and risks of the conversion option upon a fundamental change by the holder is not considered clearly and closely related to the Series B Preferred Stock. Accordingly, this embedded conversion feature was bifurcated from the Series B Preferred Stock and separately accounted for as a derivative. The Company allocated $1 million of the net proceeds received to the derivative liability based on the aggregate fair value of the embedded conversion features on the dates of issuance which reduced the original carrying value of the Series B Preferred Stock.

13

Table of Contents

The conversion option upon a fundamental change embedded derivative value at issuance was calculated as the difference between the total value of the Series B Preferred Stock and the sum of the net present value of the cash flows if the Series B Preferred Stock is redeemed on its redemption date and the values of other embedded derivatives. Other than events which alter the likelihood of a fundamental change, the value of the conversion option upon a fundamental change embedded derivative reflects the value as of the issuance date, amortized for the passage of time. The derivative amortization is reported in Other charges (income), net in the Consolidated Statement of Operations.

The carrying value of the Series B Preferred Stock embedded derivative as of both September 30, 2025 and December 31, 2024 was a liability of less than $1 million and is included in Other current liabilities at September 30, 2025 and in Other long-term liabilities at December 31, 2024 in the accompanying Consolidated Statement of Financial Position.

The carrying value of the Series B Preferred Stock is being accreted to the mandatory redemption amount using the effective interest method to Additional paid in capital in the Consolidated Statement of Financial Position as a deemed dividend from the date of issuance through the mandatory redemption date, May 28, 2026.

Series C Preferred Stock

On February 26, 2021, the Company and GO EK Ventures IV, LLC (the “Investor”) entered into a Series C Preferred Stock Purchase Agreement (the “Purchase Agreement”) pursuant to which the Company agreed to sell to the Investor, and the Investor agreed to purchase from the Company, an aggregate of 1,000,000 shares of the Company’s newly created 5.0% Series C Convertible Preferred Stock, no par value per share (the “Series C Preferred Stock”), for a purchase price of $100 per share, representing $100 million of gross proceeds to the Company. The Investor is a fund managed by Grand Oaks Capital. The Company classified the Series C Preferred Stock as temporary equity in the Consolidated Statement of Financial Position. If any shares of Series C Preferred Stock had not been converted prior to May 28, 2026, the Company would have been required to redeem such shares at $100 per share plus the amount of accrued and unpaid dividends thereon; provided that the holders of the Series C Preferred Stock had the right to extend such redemption date by up to two years.

Conversion Features

Each share of Series C Preferred Stock was convertible, at the option of each holder at any time, into shares of Common Stock at the initial conversion price of $10 per share of Common Stock. The initial conversion price and the corresponding conversion rate were subject to certain customary anti-dilution adjustments and to proportional increase in the event the liquidation preference of the Series C Preferred Stock was automatically increased. If a holder elected to convert any shares of Series C Preferred Stock during a specified period in connection with a fundamental change (as defined in the Series C Certificate of Designations), such holder could have elected to have the conversion rate adjusted and could have elected to receive a cash payment in lieu of shares for a portion of the shares of Common Stock. Such holder would have also be entitled to a payment in respect of accumulated dividends and a payment based on the present value of all required remaining dividend payments through May 28, 2026, the mandatory redemption date. Such additional payments would have been payable at the Company’s option in cash or in additional shares of Common Stock. In addition, the Company had the right to require holders to convert any shares of Series C Preferred Stock in connection with certain reorganization events in which case the conversion rate would have been adjusted, subject to certain limitations.

The Company had the right to cause the mandatory conversion of the Series C Preferred Stock into shares of Common Stock (i) at any time after February 26, 2023 if the closing price of the Common Stock had equaled or exceeded 200% of the then-effective conversion price for 45 trading days within a period of 60 consecutive trading days, or (ii) at any time after February 26, 2024 if the closing price of the Common Stock had equaled or exceeded 150% of the then-effective conversion price for 45 trading days within a period of 60 consecutive trading days.

Dividend and Other Rights

The Series C Preferred Stock had a liquidation preference of $100 per share, and the holders of Series C Preferred Stock were entitled to cumulative dividends payable quarterly “in‐kind” in the form of additional shares of Series C Preferred Stock at a rate of 5.0% per annum. All dividends owed on the Series C Preferred Stock had been declared and additional Series C shares were issued when due. Holders of the Series C Preferred Stock were also entitled to participate in any dividends paid on the Common Stock (other than stock dividends) on an as-converted basis, with such dividends on any shares of the Series C Preferred Stock being payable upon conversion of such shares of Series C Preferred Stock to Common Stock.

14

Table of Contents

Embedded Conversion Features

The Company concluded that the Series C Preferred Stock was more akin to a debt-type instrument and that the economic characteristics and risks of the conversion option upon a fundamental change by the holder was not considered clearly and closely related to the Series C Preferred Stock. Accordingly, this embedded conversion feature was bifurcated from the Series C Preferred Stock and separately accounted for as a derivative. The Company allocated $2 million of the net proceeds received to the derivative liability based on the aggregate fair value of the embedded conversion features on the dates of issuance which reduced the original carrying value of the Series C Preferred Stock.

The conversion option upon a fundamental change embedded derivative value at issuance was calculated as the difference between the total value of the Series C Preferred Stock and the sum of the net present value of the cash flows if the Series C Preferred Stock had been redeemed on its redemption date and the values of other embedded derivatives. Other than events which alter the likelihood of a fundamental change, the value of the conversion option upon a fundamental change embedded derivative reflected the value as of the issuance date, amortized for the passage of time. The derivative amortization had been reported in Other charges (income), net in the Consolidated Statement of Operations. At the time of the Series C Preferred Stock Exchange, (as defined below), the remaining liability of less than $1 million was written off.

The carrying value of the Series C Preferred Stock embedded derivative both at the time of the Series C Preferred Stock Exchange and as of December 31, 2024, was a liability of less than $1 million and was included in Other long-term liabilities in the accompanying Consolidated Statement of Financial Position.

The carrying value of the Series C Preferred Stock was being accreted to the mandatory redemption amount using the effective interest method to Additional paid in capital in the Consolidated Statement of Financial Position as a deemed dividend from the date of issuance through the mandatory redemption date, May 28, 2026.

Series C Preferred Stock Exchange

On August 8, 2025, the Company and the Investor entered into a Series C Preferred Stock Exchange Agreement (the “Series C Exchange Agreement”) pursuant to which the Investor agreed to exchange (the “Series C Preferred Stock Exchange”) 1,241,871 shares of the Company’s Series C Preferred Stock, held by the Investor (such shares, the “Series C Exchange Shares”), which represented all of the outstanding shares of the Company’s Series C Preferred Stock, for a number of shares of the Company’s common stock equal to the aggregate liquidation preference of the Series C Exchange Shares of $124,187,100 plus any accrued and unpaid dividends thereon, at an exchange rate of $8.25 per share.

The Series C Preferred Stock Exchange was consummated on August 8, 2025 (the "Exchange Date"), in connection with which the Company issued 15,103,163 shares of Common Stock to the Investor in exchange for the Series C Exchange Shares and the accrued and unpaid dividends thereon in accordance with the terms of the Series C Exchange Agreement. The carrying value of the Series C Preferred Stock as of the Exchange Date approximated $123 million. The fair value of the common stock issued approximated $106 million, which exceeded the fair value of common stock issuable pursuant to the conversion terms of the Purchase Agreement by $19 million. This amount was recorded as a deemed dividend to Additional paid in capital in the Consolidated Statement of Financial Position. Following the completion of the exchange, the Company’s obligations with respect to the Series C Preferred Stock were fully discharged.

As a result of the Series C Preferred Stock Exchange the Investor’s voting power increased from 12.9% as of December 31, 2024 to 15.7% following the Series C Preferred Stock Exchange. In addition, in connection with the Series C Preferred Stock Exchange the Investor was granted the right to nominate one member for election to the Company’s Board for so long as it holds at least 10% of the outstanding shares of common stock of the Company. In connection with the Series C Preferred Stock Exchange, the Company entered into an Amended and Restated Registration Rights Agreement that provides customary registration rights with respect to the shares of common stock issued in the Series C Preferred Stock Exchange.

15

Table of Contents

NOTE 6: LEASES

Income recognized on operating lease arrangements for the three and nine months ended September 30, 2025 and 2024 is presented below. Income recognized for sales-type lease arrangements for the three and nine months ended September 30, 2025 was $1 million and $2 million, respectively. Income recognized for sales-type lease arrangements for the three and nine months ended September 30, 2024 was less than $1 million and $1 million, respectively.

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Lease income - operating leases: |  |  |  |  |  |  |  |  |  |  |  |
Lease income |  | $ | 2 |  |  | $ | 3 |  |  | $ | 7 |  |  | $ | 7 |
Variable lease income |  |  | 1 |  |  |  | 1 |  |  |  | 4 |  |  |  | 4 |
Total lease income |  | $ | 3 |  |  | $ | 4 |  |  | $ | 11 |  |  | $ | 11 |

NOTE 7: COMMITMENTS AND CONTINGENCIES

As of September 30, 2025, the Company had outstanding letters of credit of $24 million issued under the Amended and Restated L/C Facility Agreement as well as bank guarantees and letters of credit of $2 million, surety bonds in the amount of $47 million, and restricted cash of $103 million, primarily related to cash collateral supporting the Company’s undiscounted actuarial workers’ compensation obligations with the NYS WCB, cash collateral to ensure payment of possible casualty and workers’ compensation claims, cash collateral supporting the outstanding letters of credit under the Amended and Restated L/C Facility Agreement, to ensure payment of possible legal contingencies, hedging activities, environmental liabilities, rental payments and to support various customs, tax and trade activities. The restricted cash is recorded in Current assets and Restricted cash in the Consolidated Statement of Financial Position.

Kodak’s Brazilian operations are involved in various litigation matters in Brazil and have received or been the subject of numerous governmental assessments related to indirect and other taxes in various stages of litigation, as well as civil litigation and disputes associated with former employees and contract labor. The tax matters, which comprise the majority of the litigation matters, are primarily related to federal and state value-added taxes and income taxes. Kodak’s Brazilian operations are disputing these matters and intend to vigorously defend its position. Kodak routinely assesses all these matters as to the probability of ultimately incurring a liability in its Brazilian operations and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. As of September 30, 2025, Kodak’s Brazilian operations maintained accruals of approximately $5 million for claims aggregating approximately $93 million inclusive of interest and penalties where appropriate. The unreserved portion of the indirect taxes, civil litigation and disputes involving former employees and contract labor claims, inclusive of any related interest and penalties, for which there was at least a reasonable possibility that a loss may be incurred, amounted to approximately $6 million.

In connection with assessments in Brazil, local regulations may require Kodak’s Brazilian operations to post security for a portion of the amounts in dispute. As of September 30, 2025, Kodak’s Brazilian operations have posted security composed of $7 million of pledged cash reported within Restricted cash in the Consolidated Statement of Financial Position and liens on certain Brazilian assets with a net book value of approximately $39 million. Generally, any encumbrances on the Brazilian assets would be removed to the extent the matter is resolved in favor of Kodak’s Brazilian operations. The matter securing the lien on the non-cash assets was resolved in favor of Kodak’s Brazilian operations on March 12, 2024. On September 29, 2025, the Notary Register Office confirmed the cancellation of the lien on Brazilian non-cash assets. Recognition of the enrollment by the IRS is in process and Kodak expects the process to be completed within the next several months.

In addition, Kodak is involved in various lawsuits, claims, investigations, remediations and proceedings, including, from time to time, commercial, customs, employment, environmental, tort and health and safety matters, which are being handled and defended in the ordinary course of business. Kodak is also subject, from time to time, to various assertions, claims, proceedings and requests for indemnification concerning intellectual property, including patent infringement suits involving technologies that are incorporated in a broad spectrum of Kodak’s products such as the on-going patent infringement claims brought by FUJIFILM Corporation against Eastman Kodak Company (in the US) and its German subsidiaries (in Germany) alleging that certain of Kodak’s SONORA process free plates infringe four of its patents in each jurisdiction. These matters are in various stages of investigation and litigation and are being vigorously defended. Based on information currently available, Kodak does not believe that it is probable that the outcomes in these various matters, individually or collectively, will have a material adverse effect on its financial condition or results of operations. Litigation is inherently unpredictable, and judgments could be rendered or settlements entered that could adversely affect Kodak’s

16

Table of Contents

operating results or cash flows in a particular period. Kodak routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

NOTE 8: GUARANTEES

In accordance with the terms of a settlement agreement concerning certain of the Company’s historical environmental liabilities at Eastman Business Park, a more than 1,200-acre technology center and industrial complex in Rochester, New York, in the event the historical liabilities exceed $99 million, the Company will become liable for 50% of the portion above $99 million with no limitation to the maximum potential future payments. There is no liability recorded for this guarantee.

Extended Warranty Arrangements

Kodak offers its customers extended warranty arrangements that are generally one year but may range from three months to six years after the original warranty period. The change in Kodak’s deferred revenue balance in relation to these extended warranty and maintenance arrangements from December 31, 2024 to September 30, 2025, which is reflected in Other current liabilities in the accompanying Consolidated Statement of Financial Position, was as follows:

(in millions) |  |  |
Deferred revenue on extended warranties as of December 31, 2024 |  | $ | 12 |
New extended warranty and maintenance arrangements deferred |  |  | 42 |
Recognition of extended warranty and maintenance arrangement revenue |  |  | (40 | )
Deferred revenue on extended warranties as of September 30, 2025 |  | $ | 14 |

17

Table of Contents

NOTE 9: REVENUE

Disaggregation of Revenue

The following tables present revenue disaggregated by major product and geography:

Major Product:

Three Months Ended |
September 30, 2025 |
|  |  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
Core products (1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Plates, inks and other consumables |  | $ | 120 |  |  |  | $ | 8 |  |  | $ | — |  |  | $ | — |  |  | $ | 128 |
Ongoing service arrangements |  |  | 38 |  |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 38 |
Total annuities |  |  | 158 |  |  |  |  | 8 |  |  |  | — |  |  |  | — |  |  |  | 166 |
Equipment & software |  |  | 19 |  |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 19 |
Film and chemicals |  |  | — |  |  |  |  | 74 |  |  |  | — |  |  |  | — |  |  |  | 74 |
Total Core |  |  | 177 |  |  |  |  | 82 |  |  |  | — |  |  |  | — |  |  |  | 259 |
Other (3) |  |  | — |  |  |  |  | — |  |  |  | 6 |  |  |  | 4 |  |  |  | 10 |
Total |  | $ | 177 |  |  |  |  | $ | 82 |  |  | $ | 6 |  |  | $ | 4 |  |  | $ | 269 |

Nine Months Ended |
September 30, 2025 |
|  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
Core products (1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Plates, inks and other consumables |  | $ | 363 |  |  | $ | 21 |  |  | $ | — |  |  | $ | — |  |  | $ | 384 |
Ongoing service arrangements |  |  | 109 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 109 |
Total annuities |  |  | 472 |  |  |  | 21 |  |  |  | — |  |  |  | — |  |  |  | 493 |
Equipment & software |  |  | 48 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 48 |
Film and chemicals |  |  | — |  |  |  | 208 |  |  |  | — |  |  |  | — |  |  |  | 208 |
Total Core |  |  | 520 |  |  |  | 229 |  |  |  | — |  |  |  | — |  |  |  | 749 |
Growth products (2) |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | — |  |  |  | 2 |
Other (3) |  |  | — |  |  |  | — |  |  |  | 16 |  |  |  | 12 |  |  |  | 28 |
Total |  | $ | 520 |  |  | $ | 231 |  |  | $ | 16 |  |  | $ | 12 |  |  | $ | 779 |

18

Table of Contents

Three Months Ended |
September 30, 2024 |
|  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
Core products (1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Plates, inks and other consumables |  | $ | 126 |  |  | $ | 7 |  |  | $ | — |  |  | $ | — |  |  | $ | 133 |
Ongoing service arrangements |  |  | 38 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 38 |
Total annuities |  |  | 164 |  |  |  | 7 |  |  |  | — |  |  |  | — |  |  |  | 171 |
Equipment & software |  |  | 18 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 18 |
Film and chemicals |  |  | — |  |  |  | 63 |  |  |  | — |  |  |  | — |  |  |  | 63 |
Total Core |  |  | 182 |  |  |  | 70 |  |  |  | — |  |  |  | — |  |  |  | 252 |
Growth products (2) |  |  | — |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 1 |
Other (3) |  |  | — |  |  |  | — |  |  |  | 5 |  |  |  | 3 |  |  |  | 8 |
Total |  | $ | 182 |  |  | $ | 71 |  |  | $ | 5 |  |  | $ | 3 |  |  | $ | 261 |

Nine Months Ended |
September 30, 2024 |
|  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
Core products (1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Plates, inks and other consumables |  | $ | 388 |  |  | $ | 20 |  |  | $ | — |  |  | $ | — |  |  | $ | 408 |
Ongoing service arrangements |  |  | 118 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 118 |
Total annuities |  |  | 506 |  |  |  | 20 |  |  |  | — |  |  |  | — |  |  |  | 526 |
Equipment & software |  |  | 44 |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 45 |
Film and chemicals |  |  | — |  |  |  | 179 |  |  |  | — |  |  |  | — |  |  |  | 179 |
Total Core |  |  | 550 |  |  |  | 200 |  |  |  | — |  |  |  | — |  |  |  | 750 |
Growth products (2) |  |  | — |  |  |  | 3 |  |  |  | — |  |  |  | — |  |  |  | 3 |
Other (3) |  |  | — |  |  |  | — |  |  |  | 13 |  |  |  | 11 |  |  |  | 24 |
Total |  | $ | 550 |  |  | $ | 203 |  |  | $ | 13 |  |  | $ | 11 |  |  | $ | 777 |

(1) Core includes the Print segment and the Motion Picture and Industrial Film and Chemicals businesses within the Advanced

Materials and Chemicals segment, excluding coating and product commercialization services (“Coating Services”).

(2) Growth consists of Coating Services, Analytical Services and Advanced Materials and Functional Printing within the Advanced

Materials and Chemicals segment.

(3) Other consists of Intellectual Property Licensing ("IP Licensing") within the Advanced Materials and Chemicals segment, Brand

Licensing and Eastman Business Park.

19

Table of Contents

Geography (1):

Three Months Ended |
September 30, 2025 |
|  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
United States |  | $ | 60 |  |  | $ | 61 |  |  | $ | 6 |  |  | $ | 4 |  |  | $ | 131 |
Canada |  |  | 7 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 7 |
North America |  |  | 67 |  |  |  | 61 |  |  |  | 6 |  |  |  | 4 |  |  |  | 138 |
Europe, Middle East and Africa |  |  | 70 |  |  |  | 9 |  |  |  | — |  |  |  | — |  |  |  | 79 |
Asia Pacific |  |  | 35 |  |  |  | 11 |  |  |  | — |  |  |  | — |  |  |  | 46 |
Latin America |  |  | 5 |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 6 |
Total |  | $ | 177 |  |  | $ | 82 |  |  | $ | 6 |  |  | $ | 4 |  |  | $ | 269 |

Nine Months Ended |
September 30, 2025 |
|  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
United States |  | $ | 171 |  |  | $ | 174 |  |  | $ | 16 |  |  | $ | 12 |  |  | $ | 373 |
Canada |  |  | 14 |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 15 |
North America |  |  | 185 |  |  |  | 175 |  |  |  | 16 |  |  |  | 12 |  |  |  | 388 |
Europe, Middle East and Africa |  |  | 211 |  |  |  | 24 |  |  |  | — |  |  |  | — |  |  |  | 235 |
Asia Pacific |  |  | 112 |  |  |  | 31 |  |  |  | — |  |  |  | — |  |  |  | 143 |
Latin America |  |  | 12 |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 13 |
Total |  | $ | 520 |  |  | $ | 231 |  |  | $ | 16 |  |  | $ | 12 |  |  | $ | 779 |

20

Table of Contents

Three Months Ended |
September 30, 2024 |
|  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
United States |  | $ | 56 |  |  | $ | 56 |  |  | $ | 5 |  |  | $ | 3 |  |  | $ | 120 |
Canada |  |  | 4 |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 5 |
North America |  |  | 60 |  |  |  | 57 |  |  |  | 5 |  |  |  | 3 |  |  |  | 125 |
Europe, Middle East and Africa |  |  | 74 |  |  |  | 6 |  |  |  | — |  |  |  | — |  |  |  | 80 |
Asia Pacific |  |  | 43 |  |  |  | 8 |  |  |  | — |  |  |  | — |  |  |  | 51 |
Latin America |  |  | 5 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5 |
Total |  | $ | 182 |  |  | $ | 71 |  |  | $ | 5 |  |  | $ | 3 |  |  | $ | 261 |

Nine Months Ended |
September 30, 2024 |
|  |  |  |  | Advanced |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Materials |  |  |  |  |  |  |  |  |  |
|  |  |  |  | and |  |  |  |  |  |  |  |  |  |
(in millions) |  | Print |  |  | Chemicals |  |  | Brand |  |  | All Other |  |  | Total |
United States |  | $ | 173 |  |  | $ | 161 |  |  | $ | 13 |  |  | $ | 11 |  |  | $ | 358 |
Canada |  |  | 11 |  |  |  | 2 |  |  |  | — |  |  |  | — |  |  |  | 13 |
North America |  |  | 184 |  |  |  | 163 |  |  |  | 13 |  |  |  | 11 |  |  |  | 371 |
Europe, Middle East and Africa |  |  | 234 |  |  |  | 17 |  |  |  | — |  |  |  | — |  |  |  | 251 |
Asia Pacific |  |  | 118 |  |  |  | 23 |  |  |  | — |  |  |  | — |  |  |  | 141 |
Latin America |  |  | 14 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 14 |
Total |  | $ | 550 |  |  | $ | 203 |  |  | $ | 13 |  |  | $ | 11 |  |  | $ | 777 |

(1) Sales are reported in the geographic area in which they originate.

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed trade receivables, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) in the Consolidated Statement of Financial Position. The contract assets are transferred to trade receivables when the rights to consideration become unconditional. The amount recorded for contract assets at both September 30, 2025 and December 31, 2024 was $5 million, and was reported in Other current assets in the Consolidated Statement of Financial Position. The contract liabilities primarily relate to brand licensing agreements, prepaid service contracts or upfront payments for certain equipment purchases. The amount recorded for contract liabilities in the Consolidated Statement of Financial Position at September 30, 2025 and December 31, 2024 was $98 million and $92 million, respectively, of which $45 million and $35 million, respectively, was reported in Other current liabilities and $53 million and $57 million, respectively, was reported in Other long-term liabilities.

Revenue recognized for the three and nine months ended September 30, 2025 and 2024 that was included in the contract liability balance at the beginning of the period was $9 million and $26 million, respectively, in 2025 and $9 million and $29 million, respectively, in 2024 and primarily represented revenue from prepaid service contracts and equipment sales. Contract liabilities as of September 30, 2025 included $21 million and $32 million of cash payments received during the three and nine months ended September 30, 2025, respectively. Contract liabilities as of September 30, 2024 included $17 million and $24 million of cash payments received during the three and nine months ended September 30, 2024, respectively.

Kodak does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less or for which revenue is recognized at the amount to which Kodak has the right to invoice for services performed.

21

Table of Contents

Performance obligations with an original expected length of greater than one year generally consist of deferred service contracts, operating leases and licensing arrangements. As of September 30, 2025, there was approximately $86 million of unrecognized revenue from unsatisfied performance obligations. Approximately 5% of the revenue from unsatisfied performance obligations is expected to be recognized in the remainder of 2025, 15% in each of 2026 , 2027 and 2028 and 50% thereafter.

NOTE 10: OTHER OPERATING INCOME, NET

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Gain on sale of assets (1) |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (17 | )
Other |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1 |
Total |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (16 | )

(1) In the first quarter of 2024, Kodak sold certain assets in the U.S. and recognized a gain of $17 million.

NOTE 11: OTHER CHARGES (INCOME), NET

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Interest income |  | $ | (4 | ) |  | $ | (2 | ) |  | $ | (7 | ) |  | $ | (9 | )
Loss on foreign exchange transactions |  |  | 3 |  |  |  | 1 |  |  |  | 9 |  |  |  | 7 |
Asset impairment (1) |  |  | 4 |  |  |  | — |  |  |  | 21 |  |  |  | — |
Other |  |  | (2 | ) |  |  | — |  |  |  | (2 | ) |  |  | — |
Total |  | $ | 1 |  |  | $ | (1 | ) |  | $ | 21 |  |  | $ | (2 | )

(1)
During the second quarter of 2025, Kodak recorded an impairment charge of $17 million related to its investment in Wildcat Discovery Technologies, Inc. (“Wildcat”) due to the strategic options and alternatives being contemplated by Wildcat as a result of the current economic environment. The fair value of Kodak’s investment in Wildcat was estimated using a probability weighted assessment of the various options being considered under a combination of market and income approaches (Level 3). With respect to an observable transaction for a similar investment that occurred in October 2025, Kodak recorded an additional impairment charge of $4 million related to its investment in Wildcat during the third quarter of 2025. The fair value of Kodak's investment in Wildcat was estimated using a market approach (Level 3). The carrying value of Kodak’s investment in Wildcat as of September 30, 2025 approximated $4 million.

NOTE 12: INCOME TAXES

Kodak’s income tax provision and effective tax rate were as follows:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(dollars in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Earnings (loss) from operations before income taxes |  | $ | 16 |  |  | $ | 21 |  |  | $ | (13 | ) |  | $ | 83 |
Effective tax rate |  |  | 18.8 | % |  |  | 14.3 | % |  |  | (53.8 | )% |  |  | 8.4 | %
Provision for income taxes |  |  | 3 |  |  |  | 3 |  |  |  | 7 |  |  |  | 7 |
Provision (benefit) for income taxes at U.S. statutory tax rate |  |  | 3 |  |  |  | 4 |  |  |  | (3 | ) |  |  | 17 |
Difference between tax at effective vs. statutory rate |  | $ | — |  |  | $ | (1 | ) |  | $ | 10 |  |  | $ | (10 | )

For the three and nine months ended September 30, 2025, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% was primarily attributable to: (1) the jurisdictional mix of earnings (2) the movement of valuation allowances associated with changes in net deferred tax assets from current earnings and losses and (3) a provision associated with foreign withholding taxes on undistributed earnings.

For the three and nine months ended September 30, 2024, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% was primarily attributable to: (1) the impact related to existing valuation allowances associated with changes in net

22

Table of Contents

deferred tax assets from current earnings and losses, (2) the results from operations in jurisdictions outside the U.S., (3) a provision associated with foreign withholding taxes on undistributed earnings and (4) changes in audit reserves.

In December 2021, the Organisation for Economic Cooperation and Development (“OECD”) introduced Base Erosion and Profit Shifting (“BEPS”) Pillar 2 rules that impose a global minimum tax rate of 15%. Many participating countries enacted changes which took effect in 2024. Following the review of the relevant tax law changes introduced through Pillar 2 implementation, Kodak determined that these new regulations did not have a material impact to its tax provision for the three and nine months ended September 30, 2025 and 2024.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The OBBBA did not have a material impact on Kodak's financial statements for the three and nine months ended September 30, 2025, and Kodak is still assessing the potential impact on future periods.

NOTE 13: RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS

Components of the net periodic benefit cost for all major U.S. and non-U.S. defined benefit plans are as follows:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
(in millions) |  | U.S. |  |  | Non-U.S. |  |  | U.S. |  |  | Non-U.S. |  |  | U.S. |  |  | Non-U.S. |  |  | U.S. |  |  | Non-U.S. |
Major defined benefit plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Service cost |  | $ | — |  |  | $ | — |  |  | $ | 3 |  |  | $ | — |  |  | $ | 3 |  |  | $ | 1 |  |  | $ | 10 |  |  | $ | 1 |
Interest cost |  |  | 23 |  |  |  | 4 |  |  |  | 27 |  |  |  | 5 |  |  |  | 74 |  |  |  | 12 |  |  |  | 82 |  |  |  | 14 |
Expected return on plan assets |  |  | (42 | ) |  |  | (4 | ) |  |  | (62 | ) |  |  | (5 | ) |  |  | (128 | ) |  |  | (14 | ) |  |  | (187 | ) |  |  | (14 | )
Amortization of: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Prior service cost |  |  | 3 |  |  |  | — |  |  |  | 3 |  |  |  | — |  |  |  | 9 |  |  |  | — |  |  |  | 9 |  |  |  | — |
Actuarial (gain) loss |  |  | — |  |  |  | — |  |  |  | (9 | ) |  |  | 1 |  |  |  | (7 | ) |  |  | 1 |  |  |  | (28 | ) |  |  | 1 |
Net pension (income) expense before special termination benefits and settlements |  |  | (16 | ) |  |  | — |  |  |  | (38 | ) |  |  | 1 |  |  |  | (49 | ) |  |  | — |  |  |  | (114 | ) |  |  | 2 |
Special termination benefits (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | 1 |  |  |  | — |
Settlement gain (2) |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |
Net pension (income) expense from major plans |  |  | (17 | ) |  |  | — |  |  |  | (38 | ) |  |  | 1 |  |  |  | (48 | ) |  |  | — |  |  |  | (113 | ) |  |  | 2 |
Other plans |  |  | 3 |  |  |  | — |  |  |  | — |  |  |  |  |  |  | 6 |  |  |  | — |  |  |  | — |  |  |  | 1 |
Total net pension (income) expense |  | $ | (14 | ) |  | $ | — |  |  | $ | (38 | ) |  | $ | 1 |  |  | $ | (42 | ) |  | $ | — |  |  | $ | (113 | ) |  | $ | 3 |

(1) The special termination benefits were incurred as a result of Kodak’s restructuring actions and have been included in

Restructuring costs and other in the Consolidated Statement of Operations for that period.

(2)
The settlement gain was the result of lump sum payments from KRIP and the transfer to the insurer of all obligations and responsibilities associated with an existing annuitized obligation.

On January 21, 2025, the Board of Directors of Kodak approved the termination of the Kodak Retirement Income Plan (“KRIP”), effective March 31, 2025, and no further benefits were accrued under KRIP following this date. In addition, the Board of Directors approved a defined benefit retirement plan (the “Kodak Cash Balance Plan”) as a replacement for KRIP which became effective on March 1, 2025 for new hires and on April 1, 2025 for current employees. The benefits under the Kodak Cash Balance Plan are substantially the same as those under the cash balance feature of KRIP.

23

Table of Contents

During the three months ended March 31, 2025, Kodak concluded that it was probable that the criteria for settlement accounting for KRIP would be met in 2025 as the projected cost of all settlements would exceed the sum of the service cost and interest cost components of net periodic pension cost for the year. As a result, Kodak applied settlement accounting and remeasured KRIP for each quarterly period in 2025.

The March 31, 2025 remeasurement resulted in a net actuarial loss of $68 million, comprised of an actuarial loss of $90 million related to KRIP’s projected benefit obligation ("PBO") partially offset by an asset actuarial gain of $22 million. The PBO actuarial loss of $90 million was due in part to a decrease in discount rates, partially offset by a reduction in the 30-year Treasury rate (total net impact of $22 million). The discount rate assumption used in the March 31, 2025 remeasurement was 5.26% compared to 5.45% used at December 31, 2024, and the 30-year Treasury rate used in the March 31, 2025 remeasurement was 4.59% compared to 4.75% used at December 31, 2024. The remaining actuarial loss of $68 million was due to assumption changes related to measuring the plan on a termination basis, including assumed premiums for purchasing annuities to settle obligations and the timing of lump sum payments. The expected rate of return on plan assets assumption used in the March 31, 2025 remeasurement was unchanged from the rate used at December 31, 2024 (5.20%). The asset actuarial gain of $22 million was driven by actual asset returns being higher than expected returns. The impacts from settlement accounting during the first quarter of 2025 were immaterial.

The June 30, 2025 remeasurement resulted in a net actuarial loss of $16 million, comprised of an actuarial loss associated with asset returns of $56 million, partially offset by an actuarial gain associated with the PBO of $40 million. The asset actuarial loss was driven by the adverse effect of higher long-term interest rates on the plan’s bond portfolio. The PBO actuarial gain was driven by favorable mortality and other demographic experience of $48 million, partially offset by a loss of $8 million due to lower discount rates. Th e discount rate assumption used in the June 30, 2025 remeasurement was 5.20% and the expected rate of return on plan assets assumption was unchanged from the rate used at December 31, 2024 (5.20%). The impacts from settlement accounting during the second quarter of 2025 were immaterial.

The September 30, 2025 remeasurement resulted in a net actuarial gain of $96 million, comprised of an actuarial gain associated with asset returns of $20 million, and an actuarial gain associated with the PBO of $76 million. The asset actuarial gain was driven by the positive effect of lower long-term intere st rates on the plan’s bond portfolio. The PBO actuarial gain was driven by favorable changes in the termination assumptions of $104 million related to finalization of the purchase of an annuity contract and the timing of lump sum payments, partially offset by a loss of $21 mi llion due to lower discount rates and $7 million due to demographic experience. The discount rate assumption used in the September 30, 2025 remeasurement was 5.03% and the expected rate of return on plan assets assumption was reduced from the rate used at December 31, 2024 to 3.80% to reflect the plan’s current asset class allocation. The impacts from settlement accounting during the third quarter of 2025 resulted in a settlement gain of $1 million.

Refer to Note 19, “Subsequent Events” for additional information on the KRIP termination.

24

Table of Contents

NOTE 14: EARNINGS PER SHARE

Basic earnings per share are calculated using the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share calculations include any dilutive effect of potential common shares. In periods with a net loss available to common shareholders, diluted earnings per share are calculated using weighted-average basic shares for that period, as utilizing diluted shares would be anti-dilutive to loss per share.

A reconciliation of the amounts used to calculate basic and diluted (loss) earnings per share for the three and nine months ended September 30, 2025 and 2024 follows:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net earnings (loss) |  | $ | 13 |  |  | $ | 18 |  |  | $ | (20 | ) |  | $ | 76 |
Less: Series B Preferred stock cash and accrued dividends |  |  | (1 | ) |  |  | (1 | ) |  |  | (3 | ) |  |  | (3 | )
Less: Series C Preferred stock in-kind dividends |  |  | — |  |  |  | (2 | ) |  |  | (3 | ) |  |  | (5 | )
Less: Series C Preferred stock exchange to common stock deemed dividend |  |  | (19 | ) |  |  | — |  |  |  | (19 | ) |  |  | — |
Less: Preferred stock deemed dividends |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | (1 | )
Less: Earnings attributable to Series C Preferred shareholders |  |  | — |  |  |  | (2 | ) |  |  | — |  |  |  | (9 | )
Net (loss) earnings available to common shareholders - basic |  | $ | (7 | ) |  | $ | 13 |  |  | $ | (46 | ) |  | $ | 58 |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |
Add back: Series B preferred stock cash, accrued and deemed dividends |  | $ | — |  |  | $ | 1 |  |  | $ | — |  |  | $ | 4 |
Net (loss) earnings available to common shareholders - diluted |  | $ | (7 | ) |  | $ | 14 |  |  | $ | (46 | ) |  | $ | 62 |

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions of shares) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Weighted averages shares - basic |  |  | 89.8 |  |  |  | 80.3 |  |  |  | 83.8 |  |  |  | 80.0 |
Effect of dilutive securities |  |  |  |  |  |  |  |  |  |  |  |
Unvested restricted stock units |  |  | — |  |  |  | 1.7 |  |  |  | — |  |  |  | 1.6 |
Employee stock options |  |  | — |  |  |  | 1.2 |  |  |  | — |  |  |  | 1.0 |
Series B Preferred Stock |  |  | — |  |  |  | 9.5 |  |  |  | — |  |  |  | 9.5 |
Weighted average shares — diluted |  |  | 89.8 |  |  |  | 92.7 |  |  |  | 83.8 |  |  |  | 92.1 |

As a result of the net loss available to common shareholders for the three and nine months ended September 30, 2025, Kodak calculated diluted earnings per share using weighted-average basic shares outstanding. If Kodak had reported earnings available to common shareholders for the three months ended September 30, 2025, the calculation of diluted earnings per share would have included the assumed vesting of 1.5 million unvested restricted stock units and the assumed exercise of 1.7 million stock options. For the nine months ended September 30, 2025, the calculation of diluted earnings per share would have included the assumed vesting of 1.6 million unvested restricted stock units and the assumed exercise of 1.7 million stock options.

The computation of diluted earnings per share for the three and nine months ended September 30, 2025 excluded the impact of (1) the assumed conversion of 1.0 million shares of Series B Preferred Stock and (2) the assumed exercise of 1.7 million outstanding employee stock options because the effects would have been anti-dilutive.

The computation of diluted earnings per share for the three and nine months ended September 30, 2024 excluded the impact of (1) the assumed conversion of 1.2 million shares of Series C Preferred Stock and (2) the assumed exercise of 2.6 million outstanding employee stock options because the effects would have been anti-dilutive.

25

Table of Contents

NOTE 15: SHAREHOLDERS’ EQUITY

The Company has 560 million shares of authorized stock, consisting of: (i) 500 million shares of common stock, par value $0.01 per s hare and (ii) 60 million shares of preferred stock, no par value, issuable in one or more series.

Common Stock

As of September 30, 2025 and December 31, 2024, there were 96.4 million and 80.5 million shares of common stock outstanding, respectively.

At-The-Market ("ATM") Equity Offering Program

On May 21, 2025, the Company entered into an ATM Equity Offering Sales Agreement (the “Sales Agreement”) with BofA Securities, Inc. (“BofA”), pursuant to which the Company may offer and sell up to $100 million of shares of the Company’s common stock, par value $0.01 per share (the “shares”), from time to time, in “at-the-market” offerings through BofA, as sales agent or as principal. The Company intends to use the net proceeds from the sale of the shares for general corporate purposes.

Sales of the shares, if any, will be made at prevailing market prices at the time of sale, or as otherwise agreed with BofA. BofA will receive a commission from the Company that will not exceed, but may be lower than, 3% of the gross sales price of all shares sold under the Sales Agreement.

During the third quarter of 2025, the Company sold 200,000 shares pursuant to the Sales Agreement for net proceeds of approximately $1 million.

Preferred Stock

Series B Preferred stock issued and outstanding as of both September 30, 2025 and December 31, 2024 consis ted of 1.0 m illion shares.

On August 8, 2025, the Company issued 15,103,163 shares of common stock in exchange for all outstanding shares of Series C Preferred Stock, including accrued and unpaid dividends thereon, pursuant to a Series C Preferred Stock Exchange Agreement entered into with the Investor on August 8, 2025. Following the completion of the exchange, the Company had no outstanding shares of Series C Preferred Stock and the Company’s obligations with respect to the Series C Preferred Stock were fully discharged.

Series C Preferred stock issued and outstanding as of December 31, 2024 consisted of 1.2 million shares.

Treasury Stock

Treasury stock consisted of approximately 1.5 million and 1.3 million shares as of September 30, 2025 and December 31, 2024, respectively.

26

Table of Contents

NOTE 16: OTHER COMPREHENSIVE INCOME (LOSS)

The changes in Other comprehensive income (loss) by component were as follows:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Currency translation adjustments |  |  |  |  |  |  |  |  |  |  |  |
Currency translation adjustments |  | $ | (2 | ) |  | $ | 12 |  |  | $ | 11 |  |  | $ | — |
Pension and other postretirement benefit plan changes |  |  |  |  |  |  |  |  |  |  |  |
Newly established net actuarial gain |  |  | 96 |  |  |  | — |  |  |  | 10 |  |  |  | — |
Tax provision |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Newly established net actuarial gain, net of tax |  |  | 96 |  |  |  | — |  |  |  | 10 |  |  |  | — |
Reclassification adjustments: |  |  |  |  |  |  |  |  |  |  |  |
Amortization of prior service cost (1) |  |  | 3 |  |  |  | 2 |  |  |  | 8 |  |  |  | 8 |
Amortization of actuarial gains (1) |  |  | — |  |  |  | (9 | ) |  |  | (7 | ) |  |  | (28 | )
Recognition of gains due to settlements (1) |  |  | (1 | ) |  |  | — |  |  |  | (1 | ) |  |  | — |
Total reclassification adjustments |  |  | 2 |  |  |  | (7 | ) |  |  | — |  |  |  | (20 | )
Tax provision |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Reclassification adjustments, net of tax |  |  | 2 |  |  |  | (7 | ) |  |  | — |  |  |  | (20 | )
Pension and other postretirement benefit plan changes, net of tax |  |  | 98 |  |  |  | (7 | ) |  |  | 10 |  |  |  | (20 | )
Other comprehensive income (loss) |  | $ | 96 |  |  | $ | 5 |  |  | $ | 21 |  |  | $ | (20 | )

(1)
Reclassified to Total Net Periodic Benefit Cost - refer to Note 13, "Retirement Plans and Other Postretirement Benefits".

27

Table of Contents

NOTE 17: SEGMENT INFORMATION

Kodak has three reportable segments: Print, Advanced Materials and Chemicals and Brand. Kodak’s reportable segments are based on a combination of factors that the chief operating decision maker (“CODM”) uses to evaluate and manage the business operations, including but not limited to, Kodak’s organizational structure, customer base, markets, products and services and related technologies. Kodak does not aggregate operating segments. A description of Kodak’s reportable segments follows.

Print: The Print segment is comprised of four lines of business: the Prepress Solutions business, the PROSPER business, the Software business and the Electrophotographic Printing Solutions business.

Advanced Materials and Chemicals: The Advanced Materials and Chemicals segment is comprised of four lines of business: the Industrial Film and Chemicals business, the Motion Picture business, the Advanced Materials and Functional Printing business and the IP Licensing and Analytical Services business.

Brand: The Brand segment contains the brand licensing business.

The balance of Kodak’s continuing operations, which do not meet the criteria of a reportable segment, are reported in All Other revenues and All Other Operational EBITDA, and primarily represent the operations of the Eastman Business Park.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 1 included in the 2024 Form 10-K. There are no intersegment sales between the segments.

Kodak’s CODM is the Executive Chairman and Chief Executive Officer. Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”). Operational EBITDA represents the earnings (loss) from operations excluding the provision for income taxes; non-service cost components of pension and other postemployment benefits (“OPEB”) income; depreciation and amortization expense; restructuring costs and other; stock-based compensation expense; consulting and other costs; interest expense; other operating income, net and other (charges) income, net.

The CODM uses Operational EBITDA in assessing segment performance and deciding how to allocate resources for each segment predominantly through the annual budget and forecasting process. The CODM evaluates Operational EBITDA budget-to-actual variances, changes in Operational EBITDA from prior periods and when comparing the results of each segment with one another.

Segment financial information is shown below. Asset information by reportable segment is not disclosed below as this information is not regularly provided to or used by the CODM in assessing performance and allocating resources.

28

Table of Contents

Segment Revenues, Operational EBITDA and Consolidated Earnings (Loss) from Continuing Operations Before Income Taxes

| Three Months Ended |  |  | Nine Months Ended |
| September 30, |  |  | September 30, |
| 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
(in millions) |  |  |  |  |  |  |  |  |  |  |
Print: |  |  |  |  |  |  |  |  |  |  |
Revenues from external customers | $ | 177 |  |  | $ | 182 |  |  | $ | 520 |  |  | $ | 550 |
Cost of revenues |  | 138 |  |  |  | 154 |  |  |  | 422 |  |  |  | 446 |
Selling, general and administrative expenses |  | 28 |  |  |  | 32 |  |  |  | 92 |  |  |  | 99 |
Research and development expenses |  | 3 |  |  |  | 5 |  |  |  | 11 |  |  |  | 14 |
Operational EBITDA |  | 8 |  |  |  | (9 | ) |  |  | (5 | ) |  |  | (9 | )
Advanced Materials and Chemicals: |  |  |  |  |  |  |  |  |  |  |
Revenues from external customers |  | 82 |  |  |  | 71 |  |  |  | 231 |  |  |  | 203 |
Cost of revenues |  | 55 |  |  |  | 53 |  |  |  | 166 |  |  |  | 154 |
Selling, general and administrative expenses |  | 8 |  |  |  | 9 |  |  |  | 25 |  |  |  | 25 |
Research and development expenses |  | 3 |  |  |  | 3 |  |  |  | 9 |  |  |  | 9 |
Operational EBITDA |  | 16 |  |  |  | 6 |  |  |  | 31 |  |  |  | 15 |
Brand: |  |  |  |  |  |  |  |  |  |  |
Revenues from external customers |  | 6 |  |  |  | 5 |  |  |  | 16 |  |  |  | 13 |
Selling, general and administrative expenses |  | 1 |  |  |  | 1 |  |  |  | 2 |  |  |  | 2 |
Operational EBITDA |  | 5 |  |  |  | 4 |  |  |  | 14 |  |  |  | 11 |
Total Operational EBITDA for Reportable Segments |  | 29 |  |  |  | 1 |  |  |  | 40 |  |  |  | 17 |
All Other Operational EBITDA |  | 1 |  |  |  | 1 |  |  |  | 1 |  |  |  | 2 |
Depreciation and amortization |  | (7 | ) |  |  | (8 | ) |  |  | (21 | ) |  |  | (21 | )
Restructuring costs and other |  | (1 | ) |  |  | (1 | ) |  |  | (12 | ) |  |  | (6 | )
Stock-based compensation |  | (1 | ) |  |  | (1 | ) |  |  | (4 | ) |  |  | (5 | )
Consulting and other costs (1) |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | (1 | )
Idle costs (2) |  | (1 | ) |  |  | — |  |  |  | (3 | ) |  |  | (1 | )
Other operating income, net (3) |  | — |  |  |  | — |  |  |  | — |  |  |  | 16 |
Interest expense (3) |  | (18 | ) |  |  | (14 | ) |  |  | (47 | ) |  |  | (44 | )
Pension income excluding service cost component (3) |  | 16 |  |  |  | 42 |  |  |  | 54 |  |  |  | 124 |
Other (charges) income, net (3) |  | (1 | ) |  |  | 1 |  |  |  | (21 | ) |  |  | 2 |
Consolidated earnings (loss) from continuing operations before income taxes | $ | 16 |  |  | $ | 21 |  |  | $ | (13 | ) |  | $ | 83 |

(1)
Consulting and other costs are professional services and internal costs associated with corporate strategic initiatives and litigation. Consulting and other costs included $1 million of income in the nine months ended September 30, 2025 representing insurance reimbursement of legal costs previously paid by the Company associated with investigations and litigation matters.
(2)
Consists of third-party costs such as security, maintenance and utilities required to maintain land and buildings in certain locations not used in any Kodak operations and the costs, net of any rental income received, of underutilized portions of certain properties.
(3)
As reported in the Consolidated Statement of Operations.

29

Table of Contents

A reconciliation of reportable segment revenues to consolidated revenues follows:

| Three Months Ended |  |  | Nine Months Ended |
| September 30, |  |  | September 30, |
(in millions) | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Total Reportable Segment Revenues | $ | 265 |  |  | $ | 258 |  |  | $ | 767 |  |  | $ | 766 |
All Other Revenues |  | 4 |  |  |  | 3 |  |  |  | 12 |  |  |  | 11 |
Total Consolidated Revenues | $ | 269 |  |  | $ | 261 |  |  | $ | 779 |  |  | $ | 777 |

Kodak decreased employee benefit reserves by approximately $1 million in the three months ended September 30, 2025 due to a decrease in workers' compensation reserves driven by changes in discount rates. The decrease in reserves in the three months ended September 30, 2025 impacted gross profit by approximately $1 million. There was no change in employee benefit reserves for the nine months ended September 30, 2025.

Kodak increased employee benefit reserves by approximately $2 million and $1 million in the three and nine months ended September 30, 2024, respectively. The increase in employee benefits reserves in the three months ended September 30, 2024 was primarily due to an increase in workers' compensation reserves driven by changes in discount rates. The increase in reserves in the three months ended September 30, 2024 impacted gross profit and selling, general and administrative expenses ("SG&A") by approximately $1 million each. The increase in reserves in the nine months ended September 30, 2024 did not have a significant impact on gross profit, R&D or SG&A.

Amortization and depreciation expense by segment are not included in the segment measure of profit and loss but are regularly provided to the CODM.

| Three Months Ended |  |  | Nine Months Ended |
(in millions) | September 30, |  |  | September 30, |
Intangible asset amortization expense from continuing operations: | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Print | $ | 1 |  |  | $ | 1 |  |  | $ | 3 |  |  | $ | 3 |
Total | $ | 1 |  |  | $ | 1 |  |  | $ | 3 |  |  | $ | 3 |

| Three Months Ended |  |  | Nine Months Ended |
(in millions) | September 30, |  |  | September 30, |
Depreciation expense from continuing operations: | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Print | $ | 3 |  |  | $ | 4 |  |  | $ | 11 |  |  | $ | 12 |
Advanced Materials and Chemicals |  | 2 |  |  |  | 2 |  |  |  | 6 |  |  |  | 5 |
All Other |  | 1 |  |  |  | 1 |  |  |  | 1 |  |  |  | 1 |
Total | $ | 6 |  |  | $ | 7 |  |  | $ | 18 |  |  | $ | 18 |

(in millions) | September 30, |  |  | December 31, |
Long-lived assets located in: (1) | 2025 |  |  | 2024 |
The United States | $ | 147 |  |  | $ | 143 |
Europe, Middle East and Africa |  | 5 |  |  |  | 5 |
Asia Pacific |  | 4 |  |  |  | 5 |
Canada and Latin America |  | 42 |  |  |  | 36 |
Non-U.S. countries total (2) |  | 51 |  |  |  | 46 |
Total | $ | 198 |  |  | $ | 189 |

(1) Long-lived assets are comprised of property, plant and equipment, net.

(2) Of the total non-U.S. property, plant and equipment as of September 30, 2025, $40 million was located in Brazil. Of the total

non-U.S. property, plant and equipment as of December 31, 2024, $35 million was located in Brazil.

30

Table of Contents

NOTE 18: FINANCIAL INSTRUMENTS

Kodak, as a result of its global operating and financing activities, is exposed to changes in foreign currency exchange rates and interest rates, which may adversely affect its results of operations and financial position. Kodak manages such exposures, in part, with derivative financial instruments. Foreign currency forward contracts are used to mitigate currency risk related to foreign currency denominated assets and liabilities, as well as forecasted foreign currency denominated intercompany assets.

Kodak’s exposure to changes in interest rates results from its investing and borrowing activities used to meet its liquidity needs. Kodak does not utilize financial instruments for trading or other speculative purposes.

Kodak’s foreign currency forward contracts are not designated as hedges and are marked to market through net earnings (loss) at the same time that the exposed assets and liabilities are re-measured through net earnings (loss) (both in Other charges (income), net in the Consolidated Statement of Operations). The notional amount of such contracts open at September 30, 2025 and December 31, 2024 was approximately $221 million and $251 million, respectively. The majority of the contracts of this type held by Kodak as of September 30, 2025 and December 31, 2024 are denominated in Chinese renminbi, Japanese yen and euros.

The net effect of foreign currency forward contracts in the results of operations is shown in the following table:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net loss (gain) from derivatives not designated as hedging instruments |  | $ | 2 |  |  | $ | (6 | ) |  | $ | (3 | ) |  | $ | 4 |

Kodak had no derivatives designated as hedging instruments for the three and nine months ended September 30, 2025 and 2024.

In the event of a default under any of the Company’s credit agreements, or a default under any derivative contract or similar obligation of Kodak, subject to certain minimum thresholds, the derivative counterparties would have the right, although not the obligation, to require immediate settlement of some or all open derivative contracts at their then-current fair value, but with liability positions netted against asset positions with the same counterparty.

Fair Value

Fair values of Kodak’s foreign currency forward contracts are determined using observable inputs (Level 2 fair value measurements) and are based on the present value of expected future cash flows (an income approach valuation technique) considering the risks involved and using discount rates appropriate for the duration of the contracts. The gross fair value of foreign currency forward contracts in an asset position are reported in Other current assets and the gross fair value of foreign currency forward contracts in a liability position are reported in Other current liabilities in the Consolidated Statement of Financial Position. The gross fair value of forward contracts in an asset position as of September 30, 2025 and December 31, 2024 was less than $1 million and $0 million, respectively. The gross fair value of foreign currency forward contracts in a liability position as of September 30, 2025 and December 31, 2024 was $1 million and $3 million, respectively.

Short-term debt (Level 2 fair value measurements) includes the Term Loans at September 30, 2025 for which the fair value is determined by pricing models based on the value of related cash flows discounted at current market interest rates. The fair values of short-term borrowings were $412 million and $1 million at September 30, 2025 and December 31, 2024, respectively.

The fair values of long-term debt (Level 2 fair value measurements) are determined by reference to quoted market prices of similar instruments, if available. The fair values of long-term borrowings were $10 million and $436 million at September 30, 2025 and December 31, 2024, respectively.

The carrying values of cash and cash equivalents, restricted cash and the current portion of long-term debt approximate their fair values at both September 30, 2025 and December 31, 2024.

Transfers between levels of the fair value hierarchy are recognized based on the actual date of the event or change in circumstances that caused the transfer. There were no transfers between levels of the fair value hierarchy during the three and nine months ended September 30, 2025.

31

Table of Contents

NOTE 19: SUBSEQUENT EVENTS

KRIP Termination:

On October 21, 2025, the annuity obligations with respect to all KRIP annuitants (approximately 27,000 participants and beneficiaries) representing approximately $1.8 billion of pension obligation was transferred to Metropolitan Tower Life Insurance Company through the purchase of a group annuity contract, the premium for which was funded directly and solely by the assets of KRIP. In addition, on October 1, 2025, KRIP settled approximately $76 million of pension obligations through lump-sum payments to deferred vested participants and on October 31, 2025, KRIP settled approximately $157 million of pension obligations through lump-sum payments to active participants. KRIP will transfer the remaining liabilities of approximately $15 million for missing participants and the appropriate level of assets to the PBGC missing program by the end of November 2025. Accordingly, as of the date of filing of this Form 10-Q, substantially all of the pension obligations under KRIP have been fully settled and the excess pension assets will be distributed to the Company and the Kodak Cash Balance Plan. This distribution is currently expected to take place in December 2 025.

Term Loan Credit Agreement Amendment:

On November 4, 2025, the Company and the Subsidiary Guarantors entered into the Third Amendment to the Amended and Restated Credit Agreement (the “November 2025 Term Loan Credit Agreement Amendment”) with the Term Loan Lenders and the Term Loan Agent. The November 2025 Term Loan Credit Agreement Amendment (i) modified the maturity date of the Term Loans to be August 15, 2028, (ii) eliminated the mandatory prepayment obligation requiring Kodak to use 50% of the net cash proceeds from certain transactions to prepay Term Loans below $200 million, (iii) provided the Company the option to prepay the Term Loans after May 15, 2026 with cash proceeds from certain transactions plus a 4% prepayment fee, (iv) removed limitations on restricted payments on the repurchase or redemption of the Series B Preferred Stock subject to certain restrictions and (v) removed the requirement to include reversion proceeds not used to prepay Term Loans in the calculation of Excess Cash Flow as defined in the Amended and Restated Term Loan Credit Agreement.

Letter of Credit Facility Agreement:

On November 4, 2025, the Company and the Subsidiary Guarantors entered into Amendment No. 4 to the Letter of Credit Facility Agreement (the “November 2025 L/C Facility Amendment”) with the L/C Lenders and Bank of America, N.A. The November 2025 L/C Facility Amendment (i) modified the maturity date of the facility to be May 17, 2028, the date that is 90 days prior to the maturity date of the Term Loans and (ii) removed limitations on restricted payments on the repurchase or redemption of the Series B Preferred Stock subject to certain restrictions.

32

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

CAUTIONARY STATEMENT PURSUANT TO SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This report on Form 10-Q includes “forward–looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995.

Forward–looking statements include statements concerning Kodak’s plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, liquidity, investments, financing needs and business trends and other information that is not historical information. When used in this document, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “predicts,” “forecasts,” “strategy,” “continues,” “goals,” “targets” or future or conditional verbs, such as “will,” “should,” “could,” or “may,” and similar words and expressions, as well as statements that do not relate strictly to historical or current facts, are intended to identify forward–looking statements. All forward–looking statements, including management’s examination of historical operating trends and data, are based upon Kodak’s current expectations and assumptions. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results or outcomes, or timing of actual results or outcomes, to differ materially from historical results or those expressed in or implied by such forward-looking statements. Important factors that could cause actual events, results or outcomes, or their timing, to differ materially from the forward-looking statements include, among others, the risks and uncertainties described in more detail in the Company’s Annual Report on Form 10–K for the year ended December 31, 2024 ("2024 Form 10-K") under the headings “Business,” “Risk Factors,” “Legal Proceedings,” and/or “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Liquidity and Capital Resources,” in the corresponding sections of this report on Form 10-Q and the Company’s quarterly reports on Form 10‐Q for the quarters ended March 31, 2025 and June 30, 2025, and in other filings the Company makes with the SEC from time to time, as well as the following:

•
Kodak’s ability to improve and sustain its operating structure, cash flow, profitability and other financial results;
•
Kodak’s ability to achieve strategic objectives, cash forecasts, financial projections and projected growth;
•
Kodak’s ability to achieve the financial and operational results contained in its business plans;
•
Kodak’s ability to obtain additional or alternate financing if and as needed, Kodak's continued ability to manage world-wide cash through intercompany loans, distributions and other mechanisms, and Kodak's ability to provide or facilitate financing for its customers;
•
Changes in foreign currency exchange rates, commodity prices, interest rates and tariff rates;
•
The timing and final amount of reversion proceeds actually received by Kodak from the liquidation of KRIP;
•
Kodak’s ability to fund continued investments, capital needs and collateral requirements and to service its debt and Series B Preferred Stock;
•
The impact of the global economic environment, including inflationary pressures, geopolitical issues such as the war in Ukraine and conflicts involving Israel, medical epidemics, changes in trade policies, including tariffs or other trade restrictions or the threat of such actions, and Kodak’s ability to effectively mitigate the associated increased costs of aluminum and other raw materials, energy, labor, shipping, delays in shipment and production times, and fluctuations in demand;
•
Kodak's ability to effectively compete with large, well-financed industry participants or with competitors whose cost structure is lower than Kodak's;
•
The performance by third parties of their obligations to supply products, components or services to Kodak and Kodak’s ability to address supply chain disruptions and continue to obtain raw materials and components available from single or limited sources of supply, which may be adversely affected by the war in Ukraine, the conflicts involving Israel, changes in trade policies, including tariffs or other trade restrictions or the threat of such actions, and residual effects of the COVID-19 pandemic;
•
Kodak’s ability to comply with the covenants in its various credit facilities;

33

Table of Contents

•
Kodak’s ability to effectively anticipate technology and industry trends, including related to AI, and develop and market new products, solutions and technologies, including products based on its technology and expertise that relate to industries in which it does not currently conduct material business;
•
Kodak’s ability to effect strategic transactions, such as investments, acquisitions, strategic alliances, divestitures and similar transactions, or to achieve the benefits sought to be achieved from such strategic transactions;
•
Kodak’s continued ability to manage, defend and resolve a variety of current and legacy claims without incurring material losses or disruptions to its business and to bear the costs associated with such claims;
•
Kodak's ability to discontinue, sell or spin-off certain non-core businesses or operations, or otherwise monetize assets; and
•
The potential impact of force majeure events, cyber‐attacks or other data security incidents or IT outages that could disrupt or otherwise harm Kodak’s operations.

Future events and other factors may cause Kodak’s actual results to differ materially from the forward–looking statements. All forward–looking statements attributable to Kodak or persons acting on its behalf apply only as of the date of this report on Form 10-Q and are expressly qualified in their entirety by the cautionary statements included or referenced in this document. Kodak undertakes no obligation to update or revise forward–looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events, except as required by law.

EXECUTIVE OVERVIEW

Kodak is a global manufacturer focused on commercial print and advanced materials and chemicals. With 79,000 patents earned over 130 years of research and development ("R&D"), Kodak believes in the power of technology and science to enhance what the world sees and creates. Kodak’s innovative, award-winning products, combined with its customer-first approach, make Kodak the partner of choice for commercial printers worldwide. Kodak is committed to environmental stewardship, including industry leadership in developing sustainable solutions for print.

Consolidated revenues in the three and nine months ended September 30, 2025 were $269 million and $779 million, respectively, increases of $8 million (3%) and $2 million (0%), respectively, when compared to the three and nine months ended September 30, 2024. Currency fluctuations had a favorable impact on revenues in the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024 ($4 million and $6 million, respectively).

Print revenues in the three and nine months ended September 30, 2025 were $177 million and $520 million, respectively, decreases of $5 million (3%) compared to the prior year quarter and $30 million (5%) compared to the prior year-to-date period. Print revenues accounted for 66% and 67% of Kodak’s total revenues for the three and nine months ended September 30, 2025, respectively. Advanced Materials and Chemicals revenues in the three and nine months ended September 30, 2025 were $82 million and $231 million, respectively, increases of $11 million (15%) compared to the prior year quarter and $28 million (14%) compared to the prior year-to-date period.

Economic Environment and Other Global Events:

Kodak's products are sold and serviced in numerous countries across the globe with more than half of sales generated outside the U.S. Current global economic conditions remain highly volatile due to the uncertain and unpredictable macroeconomic environment, heightened levels of inflation, the war in Ukraine, the conflicts involving Israel, changes in trade policies, including tariffs or other trade restrictions or the threat of such actions, and other global events which impacted Kodak’s operations. Kodak is experiencing revenue declines and increased manufacturing costs for certain businesses due to lower volumes and increases in labor, material and distribution costs, as well as supply chain disruptions and shortages in materials and labor.

The U.S. government imposed new tariffs on a range of imported goods, including aluminum, steel and certain raw materials and component parts used in Kodak’s manufacturing and supply chain. The tariffs imposed have resulted in increased manufacturing costs which the Company has been able to largely mitigate through pricing actions, supplier negotiations and other cost savings measures. As a result of these actions, the tariffs that have been enacted or expanded by the U.S. did not have a material adverse effect on Kodak’s operations, financial condition or cash flows for the nine months ended September 30, 2025.

Kodak is actively monitoring the tariff developments and continuing to analyze the potential impacts on its businesses, cost structure and supply chain. The Company is pursuing options to substantially mitigate the impact of the increased tariffs or any future tariffs,

34

Table of Contents

including seeking certain exemptions, offsetting cost increases through further pricing actions and additional cost savings measures, securing alternative sources of materials or products, and evaluating potential manufacturing footprint changes.

There is substantial uncertainty about the duration of existing tariffs or pauses in tariffs, tariff levels and whether additional tariffs or other retaliatory actions may be imposed, modified or suspended. Countries subject to such tariffs have imposed or may in the future impose reciprocal or retaliatory tariffs and other trade measures. These actions and the related rising political tensions could negatively impact global macroeconomic conditions and the stability of global financial markets. The ultimate impact of any tariffs is uncertain and will depend on various factors, including whether the tariffs are maintained and/or implemented, the duration of the tariffs, any exceptions or exemptions that are or may become available and the timing of their implementation, amount and scope, all of which could have a material adverse effect on Kodak’s business, financial condition and results of operations.

Kodak has implemented various pricing actions and customer-focused initiatives to mitigate the impact of increased manufacturing costs, primarily within its Print and Advanced Materials and Chemicals segments. Largely beginning in the latter part of the second quarter of 2021, in order to mitigate the impact of higher aluminum, energy and packaging costs within Prepress Solutions, the Print segment implemented pricing actions on purchases of plates that continue to be periodically reviewed and adjusted accordingly. In addition, the Advanced Materials and Chemicals segment implemented various pricing actions primarily within its Industrial Films and Chemicals and Motion Picture businesses.

The Print segment is experiencing a slowdown in customer demand for plates that negatively impacted volume due to current global economic conditions and the impact of pricing actions. In addition to the pricing actions and customer initiatives described above, Kodak has implemented supply chain and workforce optimization, productivity improvements and other cost savings activities. The combined actions have largely mitigated the impact of lower volumes and increased manufacturing costs. However, the potential worsening of economic conditions, continued decreases in volume and increases in manufacturing and other costs without further price increases, productivity improvements or other cost saving measures, could unfavorably impact this segment's operating results.

The Advanced Materials and Chemicals segment has experienced labor shortages in certain manufacturing areas. Increased demand for consumer film products along with manufacturing equipment limitations and labor shortages have contributed to increased backorders. During 2024, the Advanced Materials and Chemicals segment reduced the amount of backorders compared to levels seen in prior years. This was driven by increased headcount and capital investments in equipment upgrades and new equipment that increased capacity and streamlined processes. Increased demand for film products may continue to place stress on manufacturing equipment and the labor force without further investment or additional hiring in specific areas.

Kodak has implemented numerous measures to mitigate the challenges associated with supply chain disruptions and shortages in materials, including increasing safety stock on certain materials, increasing lead-times, providing suppliers with longer forecasts of future demand and certifying additional sources or substitute materials where possible. These measures have enabled Kodak to largely meet current demand.

Following the cessation of U.S. plate manufacturing operations by Kodak’s key competitors, Kodak has faced increasing competition in the U.S. from low-priced plates imported from China and Japan. On September 28, 2023, Kodak filed petitions with the U.S. Department of Commerce ("Commerce Department") and the U.S. International Trade Commission ("ITC") requesting relief from unfairly traded imports of plates from China and Japan in the form of the imposition of anti-dumping and/or countervailing duties on such imported plates. After making an affirmative preliminary determination on November 15, 2023, on October 22, 2024, the ITC made a final determination that a U.S. industry is materially injured by reason of imports of aluminum lithographic printing plates from China and Japan that the Commerce Department has determined are sold at less than fair value and subsidized by the government of China. The Commerce Department conducted investigations to determine dumping and subsidy margins against imports of plates manufactured in China and Japan. The Commerce Department announced preliminary findings in its countervailing duty investigation on imports of plates manufactured in China on February 27, 2024 and announced preliminary findings in its anti-dumping duty investigations on imports of plates manufactured in China and Japan on April 26, 2024, which were amended with respect to plates from China on May 28, 2024. The Commerce Department announced final findings in its anti-dumping duty investigations on imports of plates manufactured in China and Japan and its countervailing duty investigation on imports of plates manufactured in China on September 23, 2024. As a result of the determinations by the ITC and Commerce Department, duties are now being imposed on U.S. imports of plates as follows: (i) anti-dumping duties of 115.84% on such plates manufactured in China by Fuji and 317.43% on such plates manufactured in China by other entities (in each case, imposed on plates imported on or after May 1, 2024), (ii) countervailing duties of 35.66% on practically all such plates manufactured in China (imposed on plates imported on or after March 1, 2024), and (iii) anti-dumping duties of 91.83% on practically all such plates manufactured in Japan (imposed on plates imported on or after May 1, 2024). There can be no assurance that the duties imposed on imported plates will provide Kodak effective relief and will not be reduced or impaired by any appeal or other challenge.

35

Table of Contents

Kodak is monitoring the events surrounding the conflicts involving Israel and the impact on the operations of its Israel subsidiary. A leased warehouse in Israel was destroyed in 2023; however, none of Kodak’s employees were injured. While the potential impact of future developments related to this conflict is difficult to predict at this time, Kodak has been able to adapt its operations to avoid material disruption to its business. The direct operations of Kodak’s Israel subsidiary were less than 1% of total consolidated revenue and assets in 2025.

Kodak also continues to monitor the events surrounding the war in Ukraine and the various sanctions imposed in response to the war. Kodak believes it is in compliance with all sanctions. Kodak has experienced worldwide supply constraints for aluminum and increased energy and transportation costs due in part to the war in Ukraine. The extent to which the war in Ukraine will continue to impact the global economy and Kodak's business and operations remains uncertain.

The war in Ukraine and the international response have disrupted Kodak’s ability to operate its Russian subsidiary in the ordinary course, affecting its ability to pay vendors and employees, receive amounts owed from customers in Russia and deliver product. Kodak is in the process of an orderly winding down of its Russian subsidiary and has ceased its direct Russian operations. The direct operations of Kodak’s Russian subsidiary did not have a material impact on the Company’s financial statements (less than 1% of total consolidated revenues and assets for 2024, 2023 and 2022), and there were no material impacts to the consolidated results of operations for the nine months ended September 30, 2025 from the wind-down activities.

The ongoing changes in global economic conditions and the impact of other global events on Kodak’s operations and financial performance remains uncertain and will depend on several factors such as the slowdown in customer demand, the ability to offset higher labor, material and distribution costs through pricing actions, duration of supply chain disruptions and the ability to secure raw materials and components.

Kodak’s strategy:

Segments within the print industry and the film industry face competition from digital substitution. Kodak’s strategy is to:

•
Focus product investment in core competency areas of print and advanced materials, leveraging Kodak’s proprietary technologies to deliver technologically advanced products in the product goods packaging, graphic communications, and functional printing markets;
•
Generate profitable revenues through a focus on customers across Kodak’s Print segment, while increasing market share in specific markets;
•
Promote the use of film and expand the applications of Kodak’s film and chemicals to best utilize the existing infrastructure; and
•
Continue to invest in automation and streamline processes to drive cost reductions and operating efficiencies.

A discussion of opportunities and challenges related to Kodak’s strategy follows:

•
Print's digital plate products include traditional digital plates and KODAK SONORA Process Free Plates. SONORA Process Free Plates allow Kodak customers to skip the plate processing step prior to mounting plates on a printing press. This improvement in the printing process saves time and costs for customers. Also, SONORA Process Free Plates reduce the environmental impact of the printing process because they eliminate the use of chemicals (including solvents), water and power that is otherwise required to process a traditional plate. The segment's digital plate products are experiencing challenges from higher prices and availability of raw materials, digital substitution and competitive pricing pressures. Kodak seeks to mitigate the impact of increases in manufacturing costs through a combination of pricing actions, improved production efficiency and cost reduction initiatives. In addition, Kodak seeks to offset the impact of short-term and long-term market dynamics on pricing and volume pressures through innovations in Kodak product lines, including investing in digital print technologies.
•
In Print's digital printing businesses, the PROSPER Inkjet Systems product offerings are expected to grow and continue to build profitability. Kodak launched the PROSPER 7000 Turbo Press in June 2022. The PROSPER 7000 Turbo Press enables commercial, publishing and newspaper printers to compete more effectively with offset and to shift more long run jobs from conventional printing processes to inkjet. Kodak completed the placement of the first PROSPER 7000 Turbo Press in the third quarter of 2023. Investment in the next generation technology, ULTRASTREAM, is focused on the ability to place ULTRASTREAM writing systems in Kodak branded presses and in various original equipment manufacturers in applications ranging from commercial print to packaging. The first flexible packaging printing system utilizing Kodak's ULTRASTREAM

36

Table of Contents

inkjet technology was placed during the second quarter of 2022. In addition, Kodak officially launched the KODAK PROSPER ULTRA 520 Digital Press utilizing Kodak's ULTRASTREAM inkjet technology, which offers offset print quality in a smaller footprint. Kodak completed the placement of the first KODAK PROSPER ULTRA 520 Digital Press in the fourth quarter of 2023.
•
Advanced Materials and Chemicals is using Kodak’s deep expertise in chemistry and strengths in deposition and coating processes that come from decades of experience in film manufacturing to work on new initiatives:
o
EV/Energy Storage Battery Material Manufacturing - Coating of substrates is a critical aspect of manufacturing materials for batteries and Kodak plans to capitalize on its expertise in coating technology to develop opportunities in this area. Kodak utilizes its pilot coating facility to conduct development of coated electrodes for a variety of battery, fuel cell, and solar film companies as well as low volume manufacturing of electrodes. On July 13, 2022, Kodak invested $25 million to acquire a minority preferred equity interest in Wildcat Discovery Technologies, Inc. ("Wildcat"), a private technology company that uses proprietary methods to research and develop new battery materials, including an EV battery. During the second quarter of 2025, Kodak recorded an impairment charge of $17 million to its Wildcat investment due to strategic options and alternatives being contemplated by Wildcat due to the current economic environment at that time. With respect to an observable transaction for a similar investment that occurred in October 2025, Kodak recorded an additional impairment charge of $4 million related to its investment in Wildcat during the third quarter of 2025. Wildcat continues to explore and assess various options and alternatives which may further impact the value of Kodak's investment or dilute Kodak's ownership in Wildcat. Kodak also entered into an agreement to provide coating and engineering services in collaboration with Wildcat to develop and scale film coating technologies. Wildcat has granted Kodak certain rights to negotiate a production or licensing arrangement with Wildcat when and if Wildcat’s technology reaches commercial readiness. Kodak has utilized an existing production coating facility to manufacture coated substrates for EV cell assembly. Kodak is evaluating expansion or enhancement of this facility to serve a wider variety of production level customers.
o
Reagent Manufacturing - Kodak plans to capitalize on its existing chemical manufacturing expertise, including current production of unregulated Key Starting Materials for pharmaceutical products, to implement an expansion into manufacturing Diagnostic Test Reagent solutions. Kodak has completed construction of a Current Good Manufacturing Practice ("cGMP") lab and manufacturing facility at EBP and is now certified to manufacture reagents for healthcare applications.
o
Light-Blocking Technology - A proprietary technology initially developed for electrophotographic toners is being leveraged to commercialize a carbon-less fabric coating designed to offer superior light management, from complete blackout to selective light filtering, and coating compatibility with an unmatched range of fabrics and also to manage ultraviolet and/or infrared light in addition to visible light. Kodak has installed a production-scale machine to coat fabrics in EBP, located in Rochester, NY and continues to explore strategic alternatives in order to commercialize this technology.
o
Transparent Antennas - Kodak plans to leverage its proprietary copper micro-wire technologies and high-resolution printing expertise to contract-manufacture custom transparent antennas for automotive, commercial construction, and other applications requiring excellent radio frequency (“RF”) and optical performance. The integration of antennas is growing worldwide due to the rapid expansion of 5G and an overall increase in RF communications, and the ubiquity of glass surfaces makes transparent antennas attractive for multiple end-use markets. Kodak is evaluating this unique printing technology and expertise for transparent heaters to be used in biomedical analytical devices and telecom applications such as satellite dishes.
o
The Company remains interested in working with governmental agencies to leverage its assets and technology to on-shore manufacturing of pharmaceutical and other healthcare materials.
•
Film and related component manufacturing operations and Kodak Research Laboratories utilize capacity at Eastman Business Park, which helps cost absorption for both Kodak operations and tenants at Eastman Business Park.
•
Kodak plans to capitalize on its intellectual property through new business or licensing opportunities in 3D printing materials, smart material applications, and printed electronics markets.

37

Table of Contents

RESULTS OF OPERATIONS

2025 COMPARED TO 2024

THIRD QUARTER RESULTS OF OPERATIONS

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  |  |  |  | % of |  |  |  |  |  | % of |  |  | $ |  |  |  |  |  | % of |  |  |  |  |  | % of |  |  | $ |
(dollars in millions) |  | 2025 |  |  | Sales |  |  | 2024 |  |  | Sales |  |  | Change |  |  | 2025 |  |  | Sales |  |  | 2024 |  |  | Sales |  |  | Change |
Revenues |  | $ | 269 |  |  |  |  |  | $ | 261 |  |  |  |  |  | $ | 8 |  |  | $ | 779 |  |  |  |  |  | $ | 777 |  |  |  |  |  | $ | 2 |
Cost of revenues |  |  | 201 |  |  |  |  |  |  | 216 |  |  |  |  |  |  | (15 | ) |  |  | 614 |  |  |  |  |  |  | 625 |  |  |  |  |  |  | (11 | )
Gross profit |  |  | 68 |  |  |  | 25 | % |  |  | 45 |  |  |  | 17 | % |  |  | 23 |  |  |  | 165 |  |  |  | 21 | % |  |  | 152 |  |  |  | 20 | % |  |  | 13 |
Selling, general and administrative expenses |  |  | 41 |  |  |  | 15 | % |  |  | 44 |  |  |  | 17 | % |  |  | (3 | ) |  |  | 127 |  |  |  | 16 | % |  |  | 136 |  |  |  | 18 | % |  |  | (9 | )
Research and development costs |  |  | 7 |  |  |  | 3 | % |  |  | 8 |  |  |  | 3 | % |  |  | (1 | ) |  |  | 25 |  |  |  | 3 | % |  |  | 25 |  |  |  | 3 | % |  |  | — |
Restructuring costs and other |  |  | 1 |  |  |  | 0 | % |  |  | 1 |  |  |  | 0 | % |  |  | — |  |  |  | 12 |  |  |  | 2 | % |  |  | 6 |  |  |  | 1 | % |  |  | 6 |
Other operating income, net |  |  | — |  |  |  | 0 | % |  |  | — |  |  |  | 0 | % |  |  | — |  |  |  | — |  |  |  | 0 | % |  |  | (16 | ) |  |  | (2 | )% |  |  | 16 |
Earnings (loss) from operations before interest expense, pension income excluding service cost component, other charges (income), net and income taxes |  |  | 19 |  |  |  | 7 | % |  |  | (8 | ) |  |  | (3 | )% |  |  | 27 |  |  |  | 1 |  |  |  | 0 | % |  |  | 1 |  |  |  | 0 | % |  |  | — |
Interest expense |  |  | 18 |  |  |  | 7 | % |  |  | 14 |  |  |  | 5 | % |  |  | 4 |  |  |  | 47 |  |  |  | 6 | % |  |  | 44 |  |  |  | 6 | % |  |  | 3 |
Pension income excluding service cost component |  |  | (16 | ) |  |  | (6 | )% |  |  | (42 | ) |  |  | (16 | )% |  |  | 26 |  |  |  | (54 | ) |  |  | (7 | )% |  |  | (124 | ) |  |  | (16 | )% |  |  | 70 |
Other charges (income), net |  |  | 1 |  |  |  | 0 | % |  |  | (1 | ) |  |  | (0 | )% |  |  | 2 |  |  |  | 21 |  |  |  | 3 | % |  |  | (2 | ) |  |  | (0 | )% |  |  | 23 |
Earnings (loss) from operations before income taxes |  |  | 16 |  |  |  | 6 | % |  |  | 21 |  |  |  | 8 | % |  |  | (5 | ) |  |  | (13 | ) |  |  | (2 | )% |  |  | 83 |  |  |  | 11 | % |  |  | (96 | )
Provision for income taxes |  |  | 3 |  |  |  | 1 | % |  |  | 3 |  |  |  | 1 | % |  |  | — |  |  |  | 7 |  |  |  | 1 | % |  |  | 7 |  |  |  | 1 | % |  |  | — |
NET EARNINGS (LOSS) |  | $ | 13 |  |  |  | 5 | % |  | $ | 18 |  |  |  | 7 | % |  | $ | (5 | ) |  | $ | (20 | ) |  |  | (3 | )% |  | $ | 76 |  |  |  | 10 | % |  | $ | (96 | )

Revenue

Current Quarter

For the three months ended September 30, 2025 revenues increased $8 million compared with the same period in 2024, primarily driven by improved pricing in Print ($9 million) and Advanced Materials and Chemicals ($5 million), favorable foreign currency fluctuations ($4 million) and higher volume in Advanced Materials and Chemicals ($5 million) and Brand ($1 million), partially offset by a decline in Print volume ($16 million). See segment discussions for additional details.

Year-to-Date

For the nine months ended September 30, 2025 revenues increased $2 million compared with the same period in 2024, primarily driven by improved pricing in Advanced Materials and Chemicals ($19 million) and Print ($17 million), higher volume in Advanced Materials and Chemicals ($8 million) and Brand ($3 million) and favorable foreign currency fluctuations ($6 million), partially offset by lower Print volumes ($52 million). See segment discussions for additional details.

Gross Profit

Current Quarter

Gross profit for the three months ended September 30, 2025 improved $23 million compared with the same period in 2024, primarily due to improved pricing in Print ($7 million) and Advanced Materials and Chemicals ($5 million), inventory reserve adjustment in Electrophotographic Printing Solutions ("EPS") recorded in the prior year period ($4 million), lower aluminum costs ($3 million), higher volume in Advanced Materials and Chemicals ($2 million), Print ($1 million) and Brand ($1 million), net change in employee benefit reserves ($2 million) and favorable foreign currency fluctuations ($1 million). These favorable impacts were partially offset by higher manufacturing costs in Print ($3 million). See segment discussions for additional details.

Year-to-Date

Gross profit for the nine months ended September 30, 2025 improved $13 million compared with the same period in 2024, primarily due to improved pricing in Advanced Materials and Chemicals ($17 million) and Print ($15 million), inventory reserve adjustment in

38

Table of Contents

EPS recorded in the prior year period ($4 million), higher volume in Brand ($3 million), net change in employee benefit reserves ($1 million) and favorable foreign currency fluctuations ($1 million). These favorable impacts were partially offset by higher aluminum costs ($9 million), higher manufacturing costs in Print ($10 million) and Advanced Materials and Chemicals ($3 million), and a decline in Print volume ($5 million) and Advanced Materials and Chemicals ($1 million).

Selling, General and Administrative Expenses

Current Quarter

Consolidated selling and general administrative expenses ("SG&A") decreased $3 million in the three months ended September 30, 2025 compared to the prior year period due to a decline in selling and administrative costs ($2 million) related to lower costs associated with litigation matters as compared to the prior year.

Year-to-Date

Consolidated SG&A decreased $9 million in the nine months ended September 30, 2025 compared to the prior year period due to a decline in selling and administrative costs ($6 million) related to lower spending on organizational structure changes compared to the prior year period, along with a decline in consulting and project costs ($1 million) primarily related to an insurance reimbursement received in the second quarter of 2025 and a decline in equity compensation costs ($1 million).

Research and Development Costs

Consolidated R&D expenses in the three and nine months ended September 30, 2025 remained relatively flat as compared to the prior year periods.

Pension Income Excluding Service Cost Component

Pension income excluding service cost component in the three and nine months ended September 30, 2025 decreased $26 million and $70 million, respectively, compared to the prior year periods due to lower expected return on assets for the Kodak Retirement Income Plan ("KRIP") as a result of the change in investment strategy in 2024. Refer to Note 13, "Retirement Plans and Other Postretirement Benefits".

Other Operating Income, Net

For details, refer to Note 10, "Other Operating Income, Net".

Other Charges (Income), Net

For details, refer to Note 11, "Other Charges (Income), Net".

REPORTABLE SEGMENTS

Kodak has three reportable segments: Print, Advanced Materials and Chemicals and Brand. A description of Kodak’s reportable segments follows.

Print: The Print segment is comprised of four lines of business: the Prepress Solutions business, the PROSPER business, the Software business and the Electrophotographic Printing Solutions business.

Advanced Materials and Chemicals: The Advanced Materials and Chemicals segment is comprised of four lines of business: the Industrial Film and Chemicals business, the Motion Picture business, the Advanced Materials and Functional Printing business and the IP Licensing and Analytical Services business.

Brand: The Brand segment contains the brand licensing business.

All Other: All Other is comprised of the operations of the Eastman Business Park, a more than 1,200-acre technology center and industrial complex.

39

Table of Contents

Segment Revenues

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Print |  | $ | 177 |  |  | $ | 182 |  |  | $ | 520 |  |  | $ | 550 |
Advanced Materials and Chemicals |  |  | 82 |  |  |  | 71 |  |  |  | 231 |  |  |  | 203 |
Brand |  |  | 6 |  |  |  | 5 |  |  |  | 16 |  |  |  | 13 |
Total of reportable segments |  |  | 265 |  |  |  | 258 |  |  |  | 767 |  |  |  | 766 |
All Other revenues |  |  | 4 |  |  |  | 3 |  |  |  | 12 |  |  |  | 11 |
Consolidated total |  | $ | 269 |  |  | $ | 261 |  |  | $ | 779 |  |  | $ | 777 |

Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”). As demonstrated in the table below, Operational EBITDA represents consolidated earnings (loss) from operations excluding the provision for income taxes; non-service cost components of pension and other postemployment benefits (“OPEB”) income; depreciation and amortization expense; restructuring costs and other; stock-based compensation expense; consulting and other costs; idle costs; interest expense; other operating income, net and other (charges) income, net.

Segment Operational EBITDA and Consolidated Earnings (Loss) from Operations Before Income Taxes

|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
(in millions) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Print |  | $ | 8 |  |  | $ | (9 | ) |  | $ | (5 | ) |  | $ | (9 | )
Advanced Materials and Chemicals |  |  | 16 |  |  |  | 6 |  |  |  | 31 |  |  |  | 15 |
Brand |  |  | 5 |  |  |  | 4 |  |  |  | 14 |  |  |  | 11 |
All other |  |  | 1 |  |  |  | 1 |  |  |  | 1 |  |  |  | 2 |
Depreciation and amortization |  |  | (7 | ) |  |  | (8 | ) |  |  | (21 | ) |  |  | (21 | )
Restructuring costs and other |  |  | (1 | ) |  |  | (1 | ) |  |  | (12 | ) |  |  | (6 | )
Stock based compensation |  |  | (1 | ) |  |  | (1 | ) |  |  | (4 | ) |  |  | (5 | )
Consulting and other costs (1) |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | (1 | )
Idle costs (2) |  |  | (1 | ) |  |  | — |  |  |  | (3 | ) |  |  | (1 | )
Other operating income, net (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 16 |
Interest expense (3) |  |  | (18 | ) |  |  | (14 | ) |  |  | (47 | ) |  |  | (44 | )
Pension income excluding service cost component (3) |  |  | 16 |  |  |  | 42 |  |  |  | 54 |  |  |  | 124 |
Other (charges) income, net (3) |  |  | (1 | ) |  |  | 1 |  |  |  | (21 | ) |  |  | 2 |
Consolidated earnings (loss) from operations before income taxes |  | $ | 16 |  |  | $ | 21 |  |  | $ | (13 | ) |  | $ | 83 |

(1)
Consulting and other costs are professional services and internal costs associated with corporate strategic initiatives and litigation. Consulting and other costs included $1 million of income in the nine months ended September 30, 2025 representing insurance reimbursement of legal costs previously paid by the Company associated with investigations and litigation matters.
(2)
Consists of third-party costs such as security, maintenance and utilities required to maintain land and buildings in certain locations not used in any Kodak operations and the costs, net of any rental income received, of underutilized portions of certain properties.
(3)
As reported in the Consolidated Statement of Operations.

40

Table of Contents

Kodak decreased employee benefit reserves by approximately $1 million in the three months ended September 30, 2025 due to a decrease in workers' compensation reserves driven by changes in discount rates. The decrease in reserves in the three months ended September 30, 2025 impacted gross profit by approximately $1 million. There was no change to employee benefit reserves in the nine months ended September 30, 2025.

Kodak increased employee benefit reserves by approximately $2 million and $1 million in the three and nine months ended September 30, 2024, respectively. The increase in employee benefits reserves in the three months ended September 30, 2024 was primarily due to an increase in workers' compensation reserves driven by changes in discount rates. The increase in reserves in the three months ended September 30, 2024 impacted gross profit and selling, general and administrative expenses ("SG&A") by approximately $1 million each. The increase in reserves in the nine months ended September 30, 2024 did not have a significant impact on gross profit, R&D or SG&A.

PRINT SEGMENT

|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(dollars in millions) |  | 2025 |  | 2024 |  | $ Change |  | 2025 |  | 2024 |  | $ Change
Revenues |  | $177 |  | $182 |  | $(5) |  | $520 |  | $550 |  | $(30)
Operational EBITDA |  | $8 |  | $(9) |  | $17 |  | $(5) |  | $(9) |  | $4
Operational EBITDA as a % of revenues |  | 5% |  | 5% |  |  |  | 1% |  | 2% |  |

Revenues

Current Quarter

The decrease in Print revenues for the three months ended September 30, 2025 of $5 million reflected lower volumes in Prepress Solutions ($14 million) and EPS ($3 million). These unfavorable impacts were partially offset by favorable foreign currency fluctuations ($3 million), favorable pricing in Prepress Solutions ($6 million), Prosper ($2 million) and EPS ($1 million) and higher Software volumes ($1 million).

Year-to-Date

The decrease in Print revenues for the nine months ended September 30, 2025 of $30 million reflected lower volumes in Prepress Solutions ($36 million), EPS ($12 million), Software ($2 million) and Prosper ($2 million). These unfavorable impacts were partially offset by favorable pricing in Prepress Solutions ($10 million), Prosper ($5 million) and EPS ($2 million) and favorable foreign currency fluctuations ($5 million).

Operational EBITDA

Current Quarter

Print Operational EBITDA for the three months ended September 30, 2025 improved $17 million primarily related to favorable pricing in Prepress Solutions ($5 million), Prosper ($2 million) and EPS ($1 million), higher volumes for Prosper ($2 million), EPS ($1 million) and Software ($1 million), lower costs for aluminum ($3 million), lower SG&A ($2 million), net change in employee benefit reserves ($1 million), inventory reserve adjustment in EPS recorded in the prior year period ($4 million) and favorable foreign currency fluctuations ($1 million). These favorable impacts were partially offset by higher manufacturing costs ($3 million) and lower Prepress volumes ($2 million).

Year-to-Date

Print Operational EBITDA for the nine months ended September 30, 2025 improved $4 million primarily related to favorable pricing in Prepress Solutions ($8 million), Prosper ($5 million) and EPS ($2 million), lower SG&A ($6 million), higher EPS volumes ($3 million) and inventory reserve adjustment in EPS recorded in the prior year period ($4 million). These favorable impacts were partially offset by higher manufacturing costs ($10 million), higher aluminum costs ($9 million) and lower volumes in Prepress ($6 million) and Software ($1 million).

41

Table of Contents

ADVANCED MATERIALS AND CHEMICALS SEGMENT

|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(dollars in millions) |  | 2025 |  | 2024 |  | $ Change |  | 2025 |  | 2024 |  | $ Change
Revenues |  | $82 |  | $71 |  | $11 |  | $231 |  | $203 |  | $28
Operational EBITDA |  | $16 |  | $6 |  | $10 |  | $31 |  | $15 |  | $16
Operational EBITDA as a % of revenues |  | 20% |  | 8% |  |  |  | 13% |  | 7% |  |

Revenues

Current Quarter

Advanced Materials and Chemicals revenues for the three months ended September 30, 2025 improved $11 million primarily from volume increases and favorable pricing in Motion Picture ($4 million and $3 million, respectively) along with improvements in price and volume ($2 million each) in Industrial Film and Chemicals and favorable foreign currency fluctuations ($1 million).

Year-to-Date

Advanced Materials and Chemicals revenues for the nine months ended September 30, 2025 improved $28 million primarily from favorable pricing and volume increases in Industrial Film and Chemicals ($12 million and $4 million, respectively) along with improvements in price and volume ($7 million and $5 million, respectively) in Motion Picture and favorable foreign currency fluctuations ($1 million).

Operational EBITDA

Current Quarter

Advanced Materials and Chemicals Operational EBITDA improved $10 million for the three months ended September 30, 2025 as compared to the prior year quarter, primarily due to favorable pricing and volume ($3 million and $1 million, respectively) in Motion Picture, favorable pricing and volume ($2 million and $1 million, respectively) in Industrial Film and Chemical and lower SG&A ($1 million).

Year-to-Date

Advanced Materials and Chemicals Operational EBITDA improved $16 million for the nine months ended September 30, 2025 primarily due to favorable pricing in Industrial Film and Chemicals and Motion Picture ($12 million and $5 million, respectively), volume increases in Motion Picture ($2 million), lower SG&A ($1 million) and favorable foreign currency fluctuations ($1 million), partially offset by a decline in volume in Industrial Film and Chemicals ($3 million) and higher manufacturing costs ($3 million).

BRAND SEGMENT

|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(dollars in millions) |  | 2025 |  | 2024 |  | $ Change |  | 2025 |  | 2024 |  | $ Change
Revenues |  | $6 |  | $5 |  | $1 |  | $16 |  | $13 |  | $3
Operational EBITDA |  | $5 |  | $4 |  | $1 |  | $14 |  | $11 |  | $3
Operational EBITDA as a % of revenues |  | 83% |  | 80% |  |  |  | 88% |  | 85% |  |

Revenues

Brand revenues for the three and nine months ended September 30, 2025 improved by $1 million and $3 million, respectively, due to higher volumes.

Operational EBITDA

Brand Operational EBITDA for the three and nine months ended September 30, 2025 improved by $1 million and $3 million, respectively, due to higher volumes.

42

Table of Contents

RESTRUCTURING COSTS AND OTHER

Kodak recorded charges of $1 million and $12 million for the three and nine months ended September 30, 2025, respectively, in Restructuring costs and other in the Consolidated Statement of Operations.

Kodak made cash payments related to restructuring of approximately $2 million and $7 million during the three and nine months ended September 30, 2025, respectively.

The restructuring actions implemented in the first nine months of 2025 are expected to generate future annual cash savings of approximately $17 million, which are expected to reduce future annual SG&A expenses, Cost of revenues and R&D costs by $6 million, $7 million and $4 million, respectively. The majority of the annual savings are expected to be in effect by the end of 2025 as the actions are completed.

LIQUIDITY AND CAPITAL RESOURCES

Management’s Assessment of Liquidity

Kodak ended the quarter with a cash balance of $168 million, a decrease of $33 million from December 31, 2024, primarily driven by the decline in cash in the first quarter of 2025 of $43 million.

The financing transactions entered into during 2023, cash proceeds related to brand licensing arrangements in 2024 and 2023 and savings relating to rationalization, cost reductions and operational efficiencies provided additional liquidity to the Company to fund on‐going operations and to invest in growth opportunities in Kodak’s businesses of print and advanced materials and chemicals and for corporate infrastructure investments expected to contribute to improvements in cash flow.

Available liquidity includes existing cash balances. The amount of available liquidity is subject to fluctuations and includes cash balances held by various entities worldwide. At September 30, 2025 and December 31, 2024, approximately $74 million and $118 million, respectively, of cash and cash equivalents were held within the U.S. and approximately $94 million and $83 million, respectively, of cash and cash equivalents were held outside the U.S. Cash balances held outside the U.S. are generally required to support local country operations and may have high tax costs or other limitations that delay the ability to repatriate, and therefore may not be readily available for transfer to other jurisdictions. Kodak utilizes cash balances outside the U.S. to fund needs in the U.S. through the use of intercompany loans.

As of September 30, 2025 and December 31, 2024, outstanding intercompany loans to the U.S. were $508 million and $483 million, respectively, which included short-term intercompany loans from Kodak’s international finance center of $234 million and $208 million, respectively. In China, where approximately $30 million and $29 million of cash and cash equivalents was held as of September 30, 2025 and December 31, 2024, respectively, there are limitations related to net asset balances that may impact the ability to make cash available to other jurisdictions in the world. Under the terms of the Amended and Restated Term Loan Credit Agreement, the Company is permitted to invest up to $60 million (or $75 million after the Deleveraging Milestone Date) in Restricted Subsidiaries that are not Loan Parties and in joint ventures or Unrestricted Subsidiaries that are not party to the Amended and Restated Term Loan Credit Agreement.

The Company’s Hong Kong subsidiary has an intercompany loan from one of the Company’s Chinese subsidiaries with a maturity date of November 16, 2026, the proceeds of which were in turn loaned to the Company. The terms of the intercompany loan require the Company to make efforts to repay the outstanding loan balance prior to maturity. The outstanding amount of the intercompany loan as of September 30, 2025 was $68 million. The Company is evaluating repayment alternatives for the current loan agreement which would allow Kodak and its subsidiaries to perform their obligations to each other while minimizing the impact on U.S. liquidity taking into account requirements imposed by Chinese regulators. Any amounts repaid to the Chinese subsidiary may not be able to be loaned, repatriated or otherwise moved back to the U.S., in which case the Company’s U.S. liquidity would be reduced.

On May 21, 2025, the Company entered into an ATM Equity Offering Sales Agreement (the “Sales Agreement”) with BofA Securities, Inc. (“BofA”), pursuant to which the Company may offer and sell up to $100 million of shares of the Company’s common stock (the “shares”), from time to time, in “at-the-market” offerings through BofA, as sales agent or as principal. During the third quarter of 2025, the Company sold 200,000 shares pursuant to the Sales Agreement for net proceeds of approximately $1 million. The Company intends to use the net proceeds from the sale of the shares for general corporate purposes.

On November 4, 2025, the Company and the Subsidiary Guarantors entered into the Third Amendment to the Amended and Restated Credit Agreement (the “November 2025 Term Loan Credit Agreement Amendment”) with the Term Loan Lenders and the Term Loan Agent. The November 2025 Term Loan Credit Agreement Amendment (i) modified the maturity date of the Term Loans to

43

Table of Contents

be August 15, 2028, (ii) eliminated the mandatory prepayment obligation requiring Kodak to use 50% of the net cash proceeds from certain transactions to prepay Term Loans below $200 million, (iii) provided the Company the option to prepay the Term Loans after May 15, 2026 with cash proceeds from certain transactions plus a 4% prepayment fee, (iv) removed limitations on restricted payments on the repurchase or redemption of the Series B Preferred Stock subject to certain restrictions and (v) removed the requirement to include reversion proceeds not used to prepay Term Loans in the calculation of Excess Cash Flow as defined in the Amended and Restated Term Loan Credit Agreement.

On November 4, 2025, the Company and the Subsidiary Guarantors entered into Amendment No. 4 to the Letter of Credit Facility Agreement (the “November 2025 L/C Facility Amendment”) with the L/C Lenders and Bank of America, N.A. The November 2025 L/C Facility Amendment (i) modified the maturity date of the facility to be May 17, 2028, the date that is 90 days prior to the maturity date of the Term Loans and (ii) removed limitations on restricted payments on the repurchase or redemption of the Series B Preferred Stock subject to certain restrictions.

Kodak has not extended or refinanced the existing Series B Preferred Stock past the current mandatory redemption date of May 28, 2026. The carrying value of the Series B Preferred Stock as of September 30, 2025 was $99 million.

The Company will receive sufficient proceeds from the reversion of cash from KRIP in December 2025 to adequately fund the Company's debt obligations required to be paid from such proceeds or otherwise maturing within twelve months as of the filing of this Form 10-Q. See further discussion below.

Additionally, Kodak's cash flows continue to be negatively impacted by volume declines, higher manufacturing costs and increased labor, material and distribution costs, supply chain disruptions and shortages in materials and labor. The impacts from price increases, continued cost reduction actions and supply chain-related cost improvements continue to positively impact Kodak’s operations.

In order to provide flexibility to respond as necessary to changes in the business and economic environment and to maintain sufficient U.S. liquidity, Kodak may accelerate the restructuring of Kodak’s cost structure, reduce or slow spend on capital expenditures and other investments, increase prices and implement working capital improvement initiatives.

Kodak's plans to return to sustainable positive cash flow include generating profitable revenues through continued pricing actions and customer-focused initiatives, implementing effective working capital utilization, reducing operating expenses, continuing to simplify the organizational structure, investing in IT systems to drive operational efficiencies, effectively managing world-wide cash through intercompany loans, distributions or other mechanisms, generating cash from selling and leasing underutilized assets or through new licensing opportunities and implementing ways to reduce cash collateral needs. In addition, proceeds received from the settlement of the KRIP, after required debt prepayments, as further discussed below, and proceeds from the sale of common stock under the at-the-market equity offering program would be available for use for strategic growth or general corporate purposes.

The economic uncertainties surrounding the current inflationary environment and other global events represent additional elements of complexity in Kodak’s plans to return to sustainable positive cash flow. The Company cannot predict the duration and scope of such events, including the impact of rising costs of labor, commodity and distribution costs and increased product costs from tariffs, the war in Ukraine and the conflicts involving Israel, and other factors such as the ability to continue to secure raw materials and components, the ability to increase prices to offset rising product costs or how quickly and to what extent normal economic and operating conditions can resume.

Kodak Retirement Income Plan

On January 21, 2025, the Board of Directors of Kodak approved the termination of KRIP effective March 31, 2025, at which time all benefits under KRIP were frozen. In addition, the Board of Directors approved a defined benefit retirement plan (the “Kodak Cash Balance Plan”) as a replacement for KRIP which became effective on March 1, 2025 for new hires and April 1, 2025 for current employees. The benefits under the Kodak Cash Balance Plan are substantially the same as those under the cash balance feature of KRIP.

On October 21, 2025, the annuity obligations with respect to all KRIP annuitants (approximately 27,000 participants and beneficiaries) representing approximately $1.8 billion of pension obligation was transferred to Metropolitan Tower Life Insurance Company through the purchase of a group annuity contract, the premium for which was funded directly and solely by the assets of KRIP. In addition, on October 1, 2025, KRIP settled approximately $76 million of pension obligations through lump-sum payments to deferred vested participants and on October 31, 2025, KRIP settled approximately $157 million of pension obligations through lump-sum payments to active participants. KRIP will transfer the remaining liabilities of approximately $15 million for missing participants

44

Table of Contents

and the appropriate level of assets to the Pension Benefit Guaranty Corporation (“PBGC”) missing program by the end of November 2025. Upon completing the transfer of these remaining liabilities to the PBGC, all pension obligations under KRIP will be fully settled and the excess pension assets will be distributed to the Company and the Kodak Cash Balance Plan.

After KRIP’s liabilities and applicable regulatory requirements have been fully satisfied, KRIP’s surplus assets will revert to Kodak as the settlor of KRIP subject to an excise tax. KRIP will distribute surplus assets to Kodak in December 2025 ("the Reversion Date"). Based on current assumptions, Kodak estimates KRIP would have surplus assets of approximately $1 billion as of the Reversion Date. The actual amount of surplus assets will be affected by the return on KRIP’s assets prior to the Reversion Date, the amounts realized from Hedge Fund Assets in the course of their redemption, the amounts realized from distributions from KRIP private equity investments and the value of Hedge Fund Assets or private equity investments held in the KRIP portfolio at the time of reversion.

In order to reduce the amount of the surplus assets subject to excise tax and to reduce the rate of the excise tax from 50% to 20%, Kodak expects that it would direct the transfer of or otherwise contribute 25% of the surplus assets (which may include all or a significant portion of remaining non-cash assets) to the Kodak Cash Balance Plan (the “Replacement Plan”). After the capitalization of the Replacement Plan and the payment of the 20% excise tax on the remaining surplus, Kodak projects it will receive proceeds from KRIP having a value of approximately $600 million, consisting of cash of approximately $450 million and the remaining amount in non-cash assets, primarily hedge funds, which are in the process of redemption. Kodak believes no material amount of income tax would be owed on this amount due to available tax attributes. In addition to the proceeds received by Kodak from KRIP, the Replacement Plan is projected to have assets having a value of approximately $250 million which would allow Kodak to provide valuable benefits to its current employee base for the foreseeable future without additional cash cost to Kodak.

Under the terms of the November 2025 Term Loan Credit Agreement Amendment, Kodak is obligated to use 100% of the net cash proceeds of any reversion from KRIP (“Reversion Proceeds”) to prepay Term Loans outstanding under the Amended and Restated Term Loan Credit Agreement until the amount of the Term Loans is reduced to $200 million plus a 1% prepayment fee.

Kodak is required under the terms of the November 2025 Term Loan Credit Agreement Amendment, to pay down the Term Loan balance using $300 million of the expected $450 million of cash proceeds received from the KRIP reversion in December 2025. The cash proceeds from redemption of hedge funds is expected to occur over several quarters and the Company has the option to prepay the Term Loans after May 15, 2026 using Reversion Proceeds plus a 4% prepayment fee. Assuming no other prepayments are made in the interim and Kodak uses the Reversion Proceeds to prepay only the minimum amount required under the Amended and Restated Term Loan Credit Agreement, the outstanding Term Loan balance at December 31, 2025 is estimated to be approximately $200 million and will mature August 15, 2028. Based on all of the foregoing projections and after the projected mandatory prepayments of Term Loans, receipt of cash from the redemption of hedge funds and receipt of other assets, Kodak projects that it would ultimately receive cash or other assets from the KRIP surplus having a value of approximately $290 million over the next three years. Kodak expects to use excess cash proceeds received from the KRIP reversion to redeem the Series B Preferred Stock in full on or prior to its maturity date of May 28, 2026 if it has not otherwise been refinanced or the shares of Series B Preferred Stock have not been converted prior to such date.

Letter of Credit Facility Agreement

Approximately $24 million and $27 million of letters of credit were issued under the Amended and Restated L/C Facility Agreement as of September 30, 2025 and December 31, 2024, respectively. The letters of credit under the Amended and Restated L/C Facility Agreement are collateralized by cash collateral (the “L/C Cash Collateral”). The L/C Cash Collateral was $25 million and $29 million at September 30, 2025, and December 31, 2024, respectively, which was classified as Restricted Cash.

45

Table of Contents

Cash Flow

Cash, cash equivalents and restricted cash balances were as follows:

|  | September 30, |  |  | December 31, |
(in millions) |  | 2025 |  |  | 2024 |
Cash, cash equivalents and restricted cash |  | $ | 271 |  |  | $ | 301 |

Cash Flow Activity

|  | Nine Months Ended |  |  |  |
|  | September 30, |  |  |  |
(in millions) |  | 2025 |  |  | 2024 |  |  | Year-Over-Year Change |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |
Net cash used in operating activities |  | $ | (9 | ) |  | $ | (11 | ) |  | $ | 2 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |
Net cash used in investing activities |  |  | (23 | ) |  |  | (22 | ) |  |  | (1 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |
Net cash used in financing activities |  |  | (3 | ) |  |  | (21 | ) |  |  | 18 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  |  | 5 |  |  |  | (1 | ) |  |  | 6 |
Net decrease in cash, cash equivalents and restricted cash |  | $ | (30 | ) |  | $ | (55 | ) |  | $ | 25 |

Operating Activities

Net cash from operating activities for the nine months ended September 30, 2025 increased $2 million compared with the corresponding period in 2024 primarily due to a decrease in trade receivables of $52 million primarily driven by $40 million of cash proceeds related to brand licensing received in the first quarter of 2024. This was offset by a decrease in liabilities excluding borrowings and trade payables driven by Kodak’s election to pay the cash interest payment on the Term Loan entirely in PIK and a decrease in miscellaneous receivables and inventory.

Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2025 was relatively flat compared to the corresponding period in 2024 due to a decrease in proceeds from the sale of assets offset by a decrease in additions to properties.

Financing Activities

Net cash used in financing activities for the nine months ended September 30, 2025 decreased $18 million compared to the corresponding period in 2024 primarily driven by the $17 million Amended and Restated Term Loan prepayment in the prior year period.

Other Collateral Requirements

The NYS WCB requires security deposits related to self-insured workers’ compensation obligations, which security deposits are recalculated annually. Due to changes in 2019 to the manner in which the required security deposit is determined, the Company has been required to post additional collateral over the last several years. At December 31, 2022, the Company posted $75 million of collateral, representing 107% of the Company’s undiscounted actuarial workers’ compensation obligations. Effective May 1, 2023, the Company added New York to its existing workers compensation liability insurance policy and is no longer self-insured for future claims. As a result, the NYS WCB confirmed the Company will no longer be obligated to post any additional collateral. On July 1, 2025, the Company submitted a current actuarial report to the NYS WCB and requested a review of the collateral requirements. The NYS WCB confirmed no change in the collateral was required at this time.

Based on the legacy nature of the Company’s workers’ compensation obligations, the undiscounted actuarial obligation has been declining and the Company expects this trend to continue. While it may not be indicative of the rate of future declines, the undiscounted actuarial liability declined by an average of $5 million per year between 2014 and 2024. Accordingly, subject to the possibility of other changes to the calculation of required security deposits by the NYS WCB, the Company expects the amount of the

46

Table of Contents

required security deposits to decline over time and the gradual return of the security deposits that have been made or the capital used to support such security deposits.

In the third quarter of 2023, the Company deposited $68 million directly with the NYS WCB and cancelled the corresponding letter of credit supporting the associated liability. As of September 30, 2025, the Company had $45 million of surety bonds and $30 million deposited directly with the NYS WCB supporting the associated liability. The surety bonds are collateralized with $30 million of cash and the Company could be required to provide up to $15 million of cash or letters of credit to the issuers of certain surety bonds in the future to fully collateralize the bonds.

Other Uses of Cash Related to Financing Transactions

The holders of the Term Loans are entitled to quarterly cash interest payments at a rate of 7.5% per annum and holders of the Series B Preferred Stock are entitled to cumulative dividends payable quarterly in cash at a rate of 4.0% per annum. The May 2025 Term Loan Credit Agreement Amendment provides the Company the option to pay the Cash Interest Payment entirely in PIK for the next six quarterly interest payments. The Company elected to pay the Cash Interest Payment for the second and third quarters of 2025 entirely in PIK. In addition, until the second quarter of 2025, all dividends owed on the Series B Preferred Stock were declared and paid when due. No quarterly cash dividend was declared in the second and third quarters of 2025.

Series C Preferred Stock Exchange

On August 8, 2025, the Company issued 15,103,163 shares of common stock in exchange for all outstanding shares of Series C Preferred Stock, including accrued and unpaid dividends thereon, pursuant to a Series C Preferred Stock Exchange Agreement entered into with the Investor on August 8, 2025. Following the completion of the exchange, the Company had no outstanding shares of Series C Preferred Stock and the Company’s obligations with respect to the Series C Preferred Stock were fully discharged.

Defined Benefit Pension and Postretirement Plans

Kodak made net contributions (funded plans) or paid benefits (unfunded plans) totaling approximately $11 million to its non-U.S. defined benefit pension and postretirement benefit plans in the first nine months of 2025. For the balance of 2025, the forecasted contribution (funded plans) and benefit payment (unfunded plans) requirements for its pension and postretirement plans are approximately $3 million.

Capital Expenditures

Cash flows from investing activities included $28 million of capital expenditures for the nine months ended September 30, 2025. Kodak expects approximately $30 million to $40 million of total capital expenditures for fiscal year 2025.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Preparation of the Company’s Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. The accounting policies most critical to the preparation of the consolidated financial statements and that require the most difficult, subjective or complex judgments are described in Management's Discussion and Analysis of Financial Condition and Results of Operations included in the 2024 Form 10-K. There have been no material changes in the Company's critical accounting policies or estimates since December 31, 2024.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As noted in the 2024 Form 10-K, Kodak operates and conducts business in many foreign countries and as a result is exposed to fluctuations between the U.S. dollar and other currencies. Volatility in the global financial markets could increase the volatility of foreign currency exchange rates which would, in turn, impact sales and net income. For a discussion of the Company's exposure to market risk and how market risk is mitigated, refer to Part I, Item 1A "Risk Factors" and Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk", contained in the 2024 Form 10-K.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Kodak maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in Kodak’s reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and

47

Table of Contents

reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including Kodak’s Executive Chairman and Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Kodak’s management, with the participation of Kodak’s Executive Chairman and Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of Kodak’s disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q and have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, Kodak’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.

Changes in Internal Control Over Financial Reporting

Kodak is in the process of a multi-year project to modernize and enhance the Company’s global information technology systems, to improve and standardize business and financial processes and to increase the efficiency and effectiveness of financial planning and reporting. As the phased implementation occurs, it may result in changes to processes and procedures which may result in changes to internal controls over financial reporting. As such changes occur, Kodak evaluates whether they materially affect the Company’s internal controls over financial reporting.

There have been no changes identified in Kodak’s internal control over financial reporting that occurred during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, Kodak’s internal control over financial reporting.

48

Table of Contents

P art II. OTHER INFORMATION

I tem 1. Legal Proceedings

See Note 7, “Commitments and Contingencies” in the Notes to the Financial Statements included in Part I, Item 1, “Financial Statements” for information regarding certain legal proceedings in which Kodak is involved.

I tem 1A. Risk Factors

See the Risk Factors set forth in Part I, Item 1A, "Risk Factors" of the 2024 Form 10-K and those set forth in Part II, Item 1A "Risk Factors" of the Company’s quarterly reports on Form 10‐Q for the quarter ended June 30, 2025 for a detailed discussion of risk factors that could materially affect Kodak’s business, financial condition and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(a)
Sales of unregistered securities during the quarter ended September 30, 2025

None.

(b)
Issuer purchases of equity securities during the quarter ended September 30, 2025

|  |  |  |  |  |  |  | Total Number |  | Maximum Number
|  |  |  |  |  |  |  | of Shares |  | of Shares
|  |  |  |  |  |  |  | Purchased as |  | That May Yet
|  | Total Number |  |  | Average |  |  | Part of Publicly |  | Be Purchased
|  | of Shares |  |  | Price Paid |  |  | Announced Plans |  | under the Plans or
|  | Purchased (1) |  |  | per Share |  |  | or Programs (2) |  | Programs (2)
July 1 through 31, 2025 |  |  | — |  |  | $ | — |  |  | N/A |  | N/A
August 1 through 31, 2025 |  |  | 6,603 |  |  | $ | 6.69 |  |  | N/A |  | N/A
September 1 through 30, 2025 |  |  | 11,168 |  |  | $ | 5.95 |  |  | N/A |  | N/A
Total |  |  | 17,771 |  |  | $ | 6.23 |  |  |  |  |

(1)
These purchases were made to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees.

(2)
Kodak does not have a publicly announced repurchase plan or program.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. O ther Information

(c) Rule 10b5-1 Trading Plans

None.

49

Table of Contents

Item 6. Exhibits

Eastman Kodak Company

I ndex to Exhibits

Exhibit Number |
(3.1) | Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 4.1 of the Company’s Registration Statement on Form S-8 as filed on September 3, 2013).
(3.2) | Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company. (Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed on November 16, 2016).
(3.3) | Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit (3.1) of the Company’s Current Report on Form 8-K as filed on September 12, 2019).
(3.4) | Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit (3.2) of the Company’s Current Report on Form 8-K as filed on September 12, 2019).
(3.5) | Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed on December 29, 2020).
(3.6) | Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed on March 1, 2021).
(3.7) | Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K as filed on March 1, 2021).
(3.8) | Fourth Amended and Restated By-Laws of Eastman Kodak Company (Incorporated by reference to Exhibit (3.5) of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020 as filed on May 12, 2020).
(4.1) | Series C Preferred Stock Exchange Agreement, dated as of August 8, 2025, by and between Eastman Kodak Company and GO EK Ventures IV, LLC, (incorporated by reference to Exhibit (4.1) of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 as filed on August 11, 2025).
(4.2) | Amended and Restated Registration Rights Agreement, dated as of August 8, 2025, by and between Eastman Kodak Company and GO EK Ventures IV, LLC, (incorporated by reference to Exhibit (4.2) of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 as filed on August 11, 2025).
(10.1) | Third Amendment to Amended and Restated Credit Agreement, dated as of November 4, 2025, by and among the Company, the other Loan Parties named therein, the Lenders named therein and Alter Domus (US), LLC, as Administrative Agent, filed herewith.
(10.2) | Amendment No. 4 to Letter of Credit Facility Agreement, dated as of November 4, 2025, by and among the Company, the Subsidiary Guarantors named therein and Bank of America, N.A., as Agent, Lender and Issuing Bank, filed herewith.
(31.1) | Certification signed by James V. Continenza, filed herewith.
(31.2) | Certification signed by David E. Bullwinkle, filed herewith.
(32.1)(1) | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by James V. Continenza, furnished herewith.
(32.2)(1) | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 signed by David E. Bullwinkle, furnished herewith.

50

Table of Contents

(101.INS) | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document
(101.SCH) | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
(104) | Cover page formatted as Inline XBRL and contained in Exhibit 101

(1) Furnished herewith. The certifications that accompany this Quarterly Report on Form 10‑Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Quarterly Report on Form 10‑Q), irrespective of any general incorporation language contained in such filing.

51

Table of Contents

S IGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| EASTMAN KODAK COMPANY
| (Registrant)
Date: November 6, 2025 | /s/ Richard T. Michaels
| Richard T. Michaels
| Chief Accounting Officer and Corporate Controller
| (Chief Accounting Officer and Authorized Signatory)

52